Positive	O
and	O
negative	O
regulation	O
of	O
granulopoiesis	O
by	O
endogenous	B-protein
RARalpha	I-protein
.	O

Acute	O
promyelocytic	O
leukemia	O
(	O
APL	O
)	O
is	O
always	O
associated	O
with	O
chromosomal	O
translocations	O
that	O
disrupt	O
the	O
retinoic	B-DNA
acid	I-DNA
receptor	I-DNA
alpha	I-DNA
(	I-DNA
RARalpha	I-DNA
)	I-DNA
gene	I-DNA
.	O

Whether	O
these	O
translocations	O
relate	O
to	O
a	O
role	O
for	O
endogenous	B-protein
RARalpha	I-protein
in	O
normal	O
granulopoiesis	O
remains	O
uncertain	O
because	O
most	O
studies	O
addressing	O
this	O
question	O
have	O
used	O
non-physiological	O
overexpression	O
systems	O
.	O

Granulocyte	O
differentiation	O
in	O
cells	O
derived	O
from	O
RARalpha-deficient	O
(	O
RARalpha	O
(	O
-/-	O
)	O
)	O
mice	O
was	O
studied	O
and	O
evaluated	O
in	O
the	O
context	O
of	O
agonist-bound	B-protein
and	I-protein
ligand-free	I-protein
RARalpha	I-protein
.	O

Our	O
results	O
demonstrate	O
that	O
RARalpha	B-protein
is	O
dispensable	O
for	O
granulopoiesis	O
,	O
as	O
RARalpha	O
(	O
-/-	O
)	O
mice	O
have	O
a	O
normal	B-cell_type
granulocyte	I-cell_type
population	I-cell_type
despite	O
an	O
impaired	O
ability	O
to	O
respond	O
to	O
retinoids	O
.	O

However	O
,	O
although	O
it	O
is	O
not	O
absolutely	O
required	O
,	O
RARalpha	B-protein
can	O
bidirectionally	O
modulate	O
granulopoiesis	O
.	O

RARalpha	B-protein
stimulates	O
differentiation	O
in	O
response	O
to	O
exogenous	O
retinoic	O
acid	O
.	O

Furthermore	O
,	O
endogenous	O
retinoids	O
control	O
granulopoiesis	O
in	O
vivo	O
,	O
as	O
either	O
vitamin	O
A-deficient	O
mice	O
or	O
animals	O
treated	O
with	O
an	O
RAR	O
antagonist	O
accumulate	O
more	O
immature	B-cell_type
granulocytes	I-cell_type
in	O
their	O
bone	O
marrow	O
.	O

Conversely	O
,	O
RARalpha	B-protein
acts	O
to	O
limit	O
differentiation	O
in	O
the	O
absence	O
of	O
ligand	B-protein
because	O
granulocyte	B-cell_type
precursors	I-cell_type
from	O
RARalpha	O
(	O
-/-	O
)	O
mice	O
differentiate	O
earlier	O
in	O
culture	O
.	O

Thus	O
,	O
the	O
block	O
in	O
granulopoiesis	O
exerted	O
by	O
RARalpha	B-protein
fusion	B-protein
proteins	I-protein
expressed	O
in	O
APL	B-cell_type
cells	I-cell_type
may	O
correspond	O
to	O
an	O
amplification	O
of	O
a	O
normal	O
function	O
of	O
unliganded	B-protein
RARalpha	I-protein
.	O

From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

HEMATOPOIESIS	NULL
Positive	NULL
and	NULL
negative	NULL
regulation	NULL
of	NULL
granulopoiesis	NULL
by	NULL
endogenous	NULL
RARa	NULL
Philippe	NULL
Kastner	NULL
,	NULL
H.	NULL
Jeffrey	NULL
Lawrence	NULL
,	NULL
Caroline	NULL
Waltzinger	NULL
,	NULL
Norbert	NULL
B.	NULL
Ghyselinck	NULL
,	NULL
Pierre	NULL
Chambon	NULL
,	NULL
and	NULL
Susan	NULL
Chan	NULL
Acute	NULL
promyelocytic	NULL
leukemia	NULL
(	NULL
APL	NULL
)	NULL
is	NULL
always	NULL
associated	NULL
with	NULL
chromosomal	NULL
translocations	NULL
that	NULL
disrupt	NULL
the	NULL
retinoic	NULL
acid	NULL
receptor	NULL
a	NULL
(	NULL
RAR	NULL
«	NULL
)	NULL
gene	NULL
.	NULL

Whether	NULL
these	NULL
translocations	NULL
relate	NULL
to	NULL
a	NULL
role	NULL
for	NULL
endogenous	NULL
RAR	NULL
«	NULL
in	NULL
normal	NULL
granulopoiesis	NULL
remains	NULL
uncertain	NULL
because	NULL
most	NULL
studies	NULL
addressing	NULL
this	NULL
question	NULL
have	NULL
used	NULL
non-physiological	NULL
overexpression	NULL
systems	NULL
.	NULL

Granulocyte	NULL
differentiation	NULL
in	NULL
cells	NULL
derived	NULL
from	NULL
RARa	NULL
«	NULL
-deficient	NULL
(	NULL
RARa	NULL
«	NULL
~~-	NULL
)	NULL
mice	NULL
was	NULL
studied	NULL
and	NULL
evaluated	NULL
in	NULL
the	NULL
context	NULL
of	NULL
agonist-bound	NULL
and	NULL
ligand-free	NULL
RAR	NULL
«	NULL
.	NULL

Our	NULL
results	NULL
demonstrate	NULL
that	NULL
RARe	NULL
«	NULL
is	NULL
dispensable	NULL
for	NULL
granulopoiesis	NULL
,	NULL
as	NULL
RAR	NULL
&	NULL
«	NULL
~~-	NULL
mice	NULL
have	NULL
a	NULL
normal	NULL
granulocyte	NULL
population	NULL
despite	NULL
an	NULL
impaired	NULL
ability	NULL
to	NULL
respond	NULL
to	NULL
retinoids	NULL
.	NULL

However	NULL
,	NULL
although	NULL
it	NULL
is	NULL
not	NULL
absolutely	NULL
required	NULL
,	NULL
RARa	NULL
«	NULL
can	NULL
bidirectionally	NULL
modulate	NULL
granulopoiesis	NULL
.	NULL

RAR	NULL
«	NULL
stimulates	NULL
differentiation	NULL
in	NULL
response	NULL
to	NULL
exogenous	NULL
retinoic	NULL
acid	NULL
.	NULL

Furthermore	NULL
,	NULL
endogenous	NULL
retinoids	NULL
control	NULL
granulopoiesis	NULL
in	NULL
vivo	NULL
,	NULL
as	NULL
either	NULL
vitamin	NULL
A-deficient	NULL
mice	NULL
or	NULL
animals	NULL
treated	NULL
with	NULL
an	NULL
RAR	NULL
antagonist	NULL
accumulate	NULL
more	NULL
immature	NULL
granulocytes	NULL
in	NULL
their	NULL
bone	NULL
marrow	NULL
.	NULL

Conversely	NULL
,	NULL
RAR	NULL
«	NULL
acts	NULL
to	NULL
limit	NULL
differentiation	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
ligand	NULL
because	NULL
granulocyte	NULL
precursors	NULL
from	NULL
RARa	NULL
«	NULL
~~-	NULL
mice	NULL
differentiate	NULL
earlier	NULL
in	NULL
culture	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
block	NULL
in	NULL
granulopoiesis	NULL
exerted	NULL
by	NULL
RARa	NULL
«	NULL
fusion	NULL
proteins	NULL
expressed	NULL
in	NULL
APL	NULL
cells	NULL
may	NULL
correspond	NULL
to	NULL
an	NULL
amplification	NULL
of	NULL
a	NULL
normal	NULL
function	NULL
of	NULL
unliganded	NULL
RAR	NULL
«	NULL
.	NULL

(	NULL
Blood	NULL
.	NULL

2001	NULL
;	NULL
97	NULL
:	NULL
1314-1320	NULL
)	NULL
©2001	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
Introduction	NULL
The	NULL
retinoic	NULL
acid	NULL
receptor	NULL
«	NULL
(	NULL
RARa	NULL
)	NULL
gene	NULL
is	NULL
altered	NULL
by	NULL
chromosomal	NULL
translocations	NULL
in	NULL
all	NULL
cases	NULL
of	NULL
acute	NULL
promyelocytic	NULL
leukemia	NULL
(	NULL
APL	NULL
)	NULL
.	NULL

These	NULL
translocations	NULL
lead	NULL
to	NULL
the	NULL
synthesis	NULL
of	NULL
chimeric	NULL
proteins	NULL
,	NULL
resulting	NULL
from	NULL
the	NULL
fusion	NULL
of	NULL
novel	NULL
N-terminal	NULL
sequences	NULL
to	NULL
RARa	NULL
amino	NULL
acids	NULL
60-4623	NULL
To	NULL
date	NULL
,	NULL
5	NULL
distinct	NULL
fusion	NULL
partners	NULL
for	NULL
RARa	NULL
have	NULL
been	NULL
identified	NULL
,	NULL
all	NULL
of	NULL
which	NULL
belong	NULL
to	NULL
distinct	NULL
protein	NULL
families	NULL
.	NULL

PML	NULL
,	NULL
the	NULL
most	NULL
frequent	NULL
partner	NULL
,	NULL
is	NULL
a	NULL
nuclear	NULL
protein	NULL
containing	NULL
a	NULL
RING	NULL
finger	NULL
and	NULL
a	NULL
coiled	NULL
coil	NULL
.	NULL

PML	NULL
has	NULL
been	NULL
implicated	NULL
in	NULL
regulating	NULL
the	NULL
formation	NULL
and	NULL
function	NULL
of	NULL
nuclear	NULL
bodies	NULL
,	NULL
nuclear	NULL
substructures	NULL
whose	NULL
function	NULL
is	NULL
not	NULL
completely	NULL
understood	NULL
.	NULL

Less	NULL
frequent	NULL
partners	NULL
include	NULL
PLZF	NULL
(	NULL
a	NULL
zinc	NULL
finger	NULL
transcription	NULL
factor	NULL
)	NULL
,	NULL
``	NULL
NuMA	NULL
(	NULL
a	NULL
mitotic	NULL
apparatus	NULL
protein	NULL
)	NULL
,	NULL
nucleophosmin	NULL
,	NULL
'	NULL
and	NULL
STAT5b.°	NULL
Forced	NULL
expression	NULL
of	NULL
either	NULL
PML/	NULL
RARa	NULL
or	NULL
PLZF/RARa	NULL
induces	NULL
an	NULL
APL-like	NULL
disease	NULL
in	NULL
transgenic	NULL
mice	NULL
and	NULL
establishes	NULL
the	NULL
causal	NULL
role	NULL
of	NULL
these	NULL
fusion	NULL
proteins	NULL
in	NULL
APL	NULL
leukemogenesis	NULL
.	NULL
``	NULL

At	NULL
the	NULL
molecular	NULL
level	NULL
,	NULL
both	NULL
PML/RARa	NULL
and	NULL
PLZE/RARa	NULL
are	NULL
strong	NULL
repressors	NULL
,	NULL
efficiently	NULL
recruiting	NULL
a	NULL
complex	NULL
containing	NULL
the	NULL
nuclear	NULL
receptor	NULL
corepressors	NULL
N-CoR/SMRT	NULL
and	NULL
histone	NULL
deacetylase	NULL
to	NULL
target	NULL
promoters	NULL
.	NULL
``	NULL

Importantly	NULL
,	NULL
these	NULL
repressive	NULL
properties	NULL
appear	NULL
to	NULL
be	NULL
closely	NULL
linked	NULL
with	NULL
their	NULL
leukemogenic	NULL
potential	NULL
,	NULL
as	NULL
histone	NULL
deacetylase	NULL
inhibitors	NULL
can	NULL
reverse	NULL
the	NULL
leukemic	NULL
phenotype	NULL
and	NULL
lead	NULL
to	NULL
remission	NULL
in	NULL
transgenic	NULL
mouse	NULL
models	NULL
of	NULL
APL	NULL
.	NULL

Despite	NULL
accumulating	NULL
data	NULL
implicating	NULL
the	NULL
fusion	NULL
proteins	NULL
in	NULL
leuke-mia	NULL
,	NULL
relatively	NULL
little	NULL
is	NULL
known	NULL
about	NULL
how	NULL
their	NULL
action	NULL
relates	NULL
to	NULL
a	NULL
normal	NULL
function	NULL
of	NULL
RARa	NULL
during	NULL
granulopoiesis	NULL
,	NULL
the	NULL
process	NULL
by	NULL
which	NULL
immature	NULL
myeloid	NULL
cells	NULL
,	NULL
such	NULL
as	NULL
promyelocytes	NULL
,	NULL
differentiate	NULL
to	NULL
mature	NULL
neutrophils	NULL
.	NULL

In	NULL
the	NULL
hematopoietic	NULL
system	NULL
,	NULL
RARa	NULL
is	NULL
expressed	NULL
at	NULL
significant	NULL
levels	NULL
in	NULL
granulocytes	NULL
,	NULL
indicating	NULL
a	NULL
possible	NULL
function	NULL
within	NULL
this	NULL
lineage	NULL
.	NULL

'¢	NULL
``	NULL
8	NULL
RA	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
act	NULL
as	NULL
a	NULL
differentiating	NULL
agent	NULL
for	NULL
both	NULL
normal	NULL
and	NULL
transformed	NULL
immature	NULL
myeloid	NULL
cells	NULL
,	NULL
``	NULL
``	NULL
suggesting	NULL
that	NULL
the	NULL
fusion	NULL
proteins	NULL
might	NULL
antagonize	NULL
normal	NULL
RA-dependent	NULL
differentiation	NULL
.	NULL

Conversely	NULL
,	NULL
overexpression	NULL
of	NULL
wild	NULL
type	NULL
(	NULL
WT	NULL
)	NULL
RARa	NULL
(	NULL
as	NULL
well	NULL
as	NULL
dominant	NULL
negative	NULL
forms	NULL
of	NULL
this	NULL
receptor	NULL
)	NULL
has	NULL
also	NULL
been	NULL
shown	NULL
to	NULL
block	NULL
promyelocyte	NULL
differentiation	NULL
in	NULL
culture	NULL
.	NULL
``	NULL

''	NULL
Thus	NULL
,	NULL
at	NULL
limiting	NULL
RA	NULL
concen-trations	NULL
,	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
proportion	NULL
of	NULL
unliganded	NULL
RAR	NULL
molecules	NULL
may	NULL
lead	NULL
to	NULL
a	NULL
dominant-negative	NULL
inhibition	NULL
of	NULL
RA-controlled	NULL
differentiation	NULL
.	NULL

Lastly	NULL
,	NULL
RA	NULL
appears	NULL
to	NULL
orient	NULL
the	NULL
differentiation	NULL
of	NULL
pluripotent	NULL
hematopoietic	NULL
progenitors	NULL
toward	NULL
the	NULL
granulocyte	NULL
lineage	NULL
,	NULL
indicating	NULL
that	NULL
RA	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
granulocyte	NULL
fate	NULL
specification	NULL
.	NULL
``	NULL

These	NULL
various	NULL
studies	NULL
,	NULL
however	NULL
,	NULL
which	NULL
employ	NULL
either	NULL
overexpressed	NULL
receptors	NULL
or	NULL
exogenous	NULL
ligands	NULL
,	NULL
fall	NULL
short	NULL
of	NULL
demonstrating	NULL
a	NULL
physiological	NULL
role	NULL
for	NULL
endogenous	NULL
RARa	NULL
in	NULL
granulopoiesis	NULL
.	NULL

By	NULL
studying	NULL
cells	NULL
derived	NULL
from	NULL
RARa-deficient	NULL
mice	NULL
,	NULL
we	NULL
demonstrate	NULL
here	NULL
that	NULL
RARa	NULL
is	NULL
a	NULL
bidirectional	NULL
modulator	NULL
of	NULL
granulocyte	NULL
differentiation	NULL
:	NULL
In	NULL
the	NULL
absence	NULL
of	NULL
RA	NULL
,	NULL
RARa	NULL
acts	NULL
to	NULL
limit	NULL
granulocyte	NULL
differentiation	NULL
;	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
RA	NULL
,	NULL
RARa	NULL
stimulates	NULL
differentiation	NULL
.	NULL

Materials	NULL
and	NULL
methods	NULL
Mice	NULL
RARa-	NULL
and	NULL
RARy-deficient	NULL
mice	NULL
were	NULL
described	NULL
previously	NULL
.	NULL
``	NULL

Mice	NULL
were	NULL
genotyped	NULL
by	NULL
polymerase	NULL
chain	NULL
reaction	NULL
(	NULL
PCR	NULL
)	NULL
(	NULL
primers	NULL
available	NULL
upon	NULL
request	NULL
)	NULL
.	NULL

All	NULL
mice	NULL
used	NULL
in	NULL
this	NULL
study	NULL
were	NULL
between	NULL
2	NULL
and	NULL
6	NULL
months	NULL
of	NULL
age	NULL
.	NULL

Vitamin	NULL
A	NULL
deficiency	NULL
(	NULL
VAD	NULL
)	NULL
in	NULL
cellular	NULL
retinol-binding	NULL
protein	NULL
type	NULL
I	NULL
(	NULL
CRBPI	NULL
)	NULL
``	NULL
~	NULL
mice	NULL
was	NULL
produced	NULL
by	NULL
maintaining	NULL
CRBPI	NULL
'~	NULL
mice	NULL
(	NULL
all	NULL
males	NULL
)	NULL
From	NULL
the	NULL
Institut	NULL
de	NULL
Génétique	NULL
et	NULL
de	NULL
Biologie	NULL
Moléculaire	NULL
et	NULL
Cellulaire	NULL
,	NULL
!	NULL

llkirch	NULL
,	NULL
France	NULL
.	NULL

Submitted	NULL
August	NULL
24	NULL
,	NULL
2000	NULL
;	NULL
accepted	NULL
November	NULL
2	NULL
,	NULL
2000	NULL
.	NULL

Supported	NULL
by	NULL
grants	NULL
from	NULL
the	NULL
Association	NULL
pour	NULL
la	NULL
Recherche	NULL
sur	NULL
le	NULL
Cancers	NULL
;	NULL
the	NULL
Centre	NULL
National	NULL
pour	NULL
la	NULL
Recherche	NULL
Scientifique	NULL
;	NULL
the	NULL
Institut	NULL
National	NULL
de	NULL
la	NULL
Santé	NULL
et	NULL
de	NULL
la	NULL
Recherche	NULL
Médicale	NULL
;	NULL
the	NULL
Hopital	NULL
Universitaire	NULL
de	NULL
Strasbourg	NULL
;	NULL
the	NULL
College	NULL
de	NULL
France	NULL
,	NULL
llikirch	NULL
Cedex	NULL
,	NULL
France	NULL
;	NULL
and	NULL
Bristol-Myers	NULL
Squibb	NULL
,	NULL
Princeton	NULL
,	NULL
NJ	NULL
.	NULL

H.J.L..	NULL
is	NULL
the	NULL
recipient	NULL
of	NULL
a	NULL
VA	NULL
Career	NULL
Development	NULL
Award	NULL
.	NULL

BMS493	NULL
was	NULL
provided	NULL
by	NULL
Bristol-Myers	NULL
Squibb	NULL
.	NULL

1314	NULL
Reprints	NULL
:	NULL
Philippe	NULL
Kastner	NULL
and	NULL
Susan	NULL
Chan	NULL
,	NULL
Institut	NULL
de	NULL
Génétique	NULL
et	NULL
de	NULL
Biologie	NULL
Moléculaire	NULL
et	NULL
Cellulaire	NULL
,	NULL
CNRS-INSERM-ULP-College	NULL
de	NULL
France	NULL
,	NULL
BP163	NULL
,	NULL
67404	NULL
lllkirch	NULL
Cedex	NULL
,	NULL
France	NULL
;	NULL
e-mail	NULL
:	NULL
scpk	NULL
@	NULL
igbmc.u-strasbg	NULL
fr	NULL
.	NULL

The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

Therefore	NULL
,	NULL
and	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
,	NULL
this	NULL
article	NULL
is	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

section	NULL
1734	NULL
.	NULL

©2001	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
BLOOD	NULL
,	NULL
1	NULL
MARCH	NULL
2001	NULL
«	NULL
VOLUME	NULL
97	NULL
,	NULL
NUMBER	NULL
5	NULL
From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

BLOOD	NULL
,	NULL
1	NULL
MARCH	NULL
2001	NULL
»	NULL
VOLUME	NULL
97	NULL
,	NULL
NUMBER	NULL
5	NULL
RARB	NULL
«	NULL
&	NULL
HPRT	NULL
®	NULL
@	NULL
#	NULL
a	NULL
»	NULL
@	NULL
Figure	NULL
1	NULL
.	NULL

RARs	NULL
are	NULL
dispensable	NULL
for	NULL
granulopoiesis	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Fluorescence-activated	NULL
cell	NULL
sorter	NULL
(	NULL
FACS	NULL
)	NULL
profile	NULL
of	NULL
WT	NULL
and	NULL
RAR	NULL
«	NULL
~~RARy~'~	NULL
double	NULL
mutant	NULL
E14.5	NULL
FL	NULL
cells	NULL
stained	NULL
for	NULL
GR-1	NULL
and	NULL
Mac-1	NULL
expression	NULL
.	NULL

(	NULL
B	NULL
)	NULL
RT-PCR	NULL
analysis	NULL
of	NULL
granulocyte	NULL
marker	NULL
expression	NULL
in	NULL
E14.5	NULL
FL	NULL
from	NULL
WT	NULL
or	NULL
~	NULL
mice	NULL
.	NULL

(	NULL
C	NULL
)	NULL
May-Grinwald	NULL
Giemsa	NULL
staining	NULL
of	NULL
cells	NULL
from	NULL
granulocyte-macrophage	NULL
colonies	NULL
derived	NULL
from	NULL
E14.5	NULL
WT	NULL
and	NULL
RAR	NULL
«	NULL
~~RARy	NULL
~~	NULL
FL	NULL
cells	NULL
showing	NULL
morphologically	NULL
normal	NULL
neutrophils	NULL
and	NULL
macrophages	NULL
.	NULL

(	NULL
D	NULL
)	NULL
Absence	NULL
of	NULL
RARB	NULL
expression	NULL
in	NULL
FL	NULL
or	NULL
pooled	NULL
colonies	NULL
(	NULL
C	NULL
)	NULL
derived	NULL
from	NULL
WT	NULL
or	NULL
RARe~~RARy	NULL
~	NULL
mutants	NULL
.	NULL

cDNA	NULL
from	NULL
E8.5	NULL
embryos	NULL
(	NULL
E	NULL
)	NULL
was	NULL
used	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
.	NULL

on	NULL
a	NULL
VAD	NULL
diet	NULL
for	NULL
at	NULL
least	NULL
16	NULL
weeks	NULL
after	NULL
birth	NULL
.	NULL
``	NULL

''	NULL
VAD	NULL
was	NULL
confirmed	NULL
by	NULL
the	NULL
observation	NULL
of	NULL
several	NULL
VAD-related	NULL
phenotypes	NULL
:	NULL
keratinization	NULL
of	NULL
the	NULL
seminal	NULL
vesicle	NULL
and	NULL
prostate	NULL
epithelia	NULL
,	NULL
testis	NULL
degeneration	NULL
,	NULL
and	NULL
retinal	NULL
defects	NULL
.	NULL
``	NULL

These	NULL
symptoms	NULL
were	NULL
specifically	NULL
observed	NULL
in	NULL
CRBPI~-	NULL
mice	NULL
fed	NULL
a	NULL
VAD	NULL
diet	NULL
,	NULL
not	NULL
in	NULL
control	NULL
mice	NULL
(	NULL
ie	NULL
,	NULL
WT	NULL
mice	NULL
fed	NULL
a	NULL
VAD	NULL
diet	NULL
or	NULL
CRBPI~~	NULL
mice	NULL
fed	NULL
a	NULL
normal	NULL
diet	NULL
)	NULL
.	NULL

All-trans-retinoic	NULL
acid	NULL
(	NULL
ATRA	NULL
)	NULL
(	NULL
Sigma	NULL
Chemical	NULL
Co	NULL
,	NULL
St	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
and	NULL
the	NULL
pan-RAR	NULL
antagonist	NULL
BMS493	NULL
were	NULL
dissolved	NULL
in	NULL
ethanol	NULL
and	NULL
then	NULL
placed	NULL
in	NULL
an	NULL
emulsion	NULL
with	NULL
corn	NULL
oil	NULL
by	NULL
vigorous	NULL
vortexing	NULL
.	NULL

The	NULL
emulsion	NULL
was	NULL
administered	NULL
to	NULL
test	NULL
animals	NULL
by	NULL
gavage	NULL
every	NULL
12	NULL
hours	NULL
(	NULL
BMS493	NULL
)	NULL
or	NULL
every	NULL
36	NULL
hours	NULL
(	NULL
ATRA	NULL
)	NULL
for	NULL
3	NULL
days	NULL
.	NULL

Bone	NULL
marrow	NULL
(	NULL
BM	NULL
)	NULL
cells	NULL
were	NULL
harvested	NULL
by	NULL
flushing	NULL
femurs	NULL
with	NULL
medium	NULL
.	NULL

Fetal	NULL
liver	NULL
(	NULL
FL	NULL
)	NULL
cell	NULL
suspensions	NULL
were	NULL
prepared	NULL
by	NULL
sequential	NULL
passage	NULL
of	NULL
dissected	NULL
FLs	NULL
through	NULL
18-	NULL
,	NULL
22-	NULL
,	NULL
and	NULL
25-gauge	NULL
needles	NULL
.	NULL

Cell	NULL
culture	NULL
Liquid	NULL
myeloid	NULL
cultures	NULL
were	NULL
performed	NULL
by	NULL
seeding	NULL
2	NULL
X	NULL
10°	NULL
BM	NULL
cells	NULL
in	NULL
10	NULL
mL	NULL
Iscoves	NULL
modified	NULL
Dulbecco	NULL
medium	NULL
supplemented	NULL
with	NULL
20	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
(	NULL
Gibco-BRL	NULL
Life	NULL
Technologies	NULL
,	NULL
Grand	NULL
Island	NULL
,	NULL
NJ	NULL
)	NULL
,	NULL
5	NULL
ng/mL	NULL
granulocyte	NULL
colony-stimulating	NULL
factor	NULL
(	NULL
G-CSF	NULL
)	NULL
,	NULL
and	NULL
5	NULL
ng/mL	NULL
stem	NULL
cell	NULL
factor	NULL
(	NULL
SCF	NULL
)	NULL
(	NULL
R	NULL
&	NULL
D	NULL
Systems	NULL
,	NULL
Minneapolis	NULL
,	NULL
MN	NULL
)	NULL
,	NULL
penicillin/streptomycin	NULL
,	NULL
and	NULL
L-glutamine	NULL
(	NULL
2	NULL
mM	NULL
final	NULL
concentration	NULL
)	NULL
.	NULL

Ligands	NULL
were	NULL
added	NULL
in	NULL
10	NULL
pL	NULL
volumes	NULL
from	NULL
a	NULL
10-3	NULL
M	NULL
solution	NULL
in	NULL
ethanol	NULL
.	NULL

Labeling	NULL
with	NULL
5-	NULL
and	NULL
6-carboxy	NULL
fluorescein	NULL
diacetate	NULL
,	NULL
succinimidyl	NULL
ester	NULL
(	NULL
CFSE	NULL
)	NULL
(	NULL
Molecular	NULL
Probes	NULL
,	NULL
Eu-gene	NULL
,	NULL
OR	NULL
)	NULL
was	NULL
performed	NULL
by	NULL
incubating	NULL
BM	NULL
cells	NULL
for	NULL
10	NULL
minutes	NULL
at	NULL
37°C	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
10	NULL
``	NULL
cells	NULL
per	NULL
mL	NULL
in	NULL
medium	NULL
supplemented	NULL
with	NULL
2	NULL
uL/mL	NULL
E	NULL
)	NULL
B	NULL
wr	NULL
control	NULL
‘	NULL
RARa~/~	NULL
#	NULL
«	NULL
L	NULL
%	NULL
``	NULL
s.	NULL
x	NULL
.	NULL

=	NULL
ho	NULL
Jk	NULL
colony	NULL
number	NULL
(	NULL
per	NULL
51104	NULL
bone	NULL
marrow	NULL
cati	NULL
;	NULL
9CRA	NULL
,	NULL
-	NULL
_+	NULL
=	NULL
+	NULL
WT	NULL
_	NULL
RARa~	NULL
!	NULL

~	NULL
Figure	NULL
2	NULL
.	NULL

RAR	NULL
«	NULL
~~	NULL
myeloid	NULL
progenitors	NULL
are	NULL
resistant	NULL
to	NULL
the	NULL
inhibitory	NULL
effects	NULL
of	NULL
9C-RA	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Numbers	NULL
of	NULL
colonies	NULL
developing	NULL
from	NULL
5	NULL
x	NULL
10+	NULL
BM	NULL
cells	NULL
from	NULL
WT	NULL
or	NULL
RARa~~	NULL
mice	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
10~®	NULL
M	NULL
9C-RA	NULL
.	NULL

Each	NULL
bar	NULL
represents	NULL
the	NULL
average	NULL
of	NULL
duplicate	NULL
samples	NULL
from	NULL
3	NULL
mice	NULL
.	NULL

The	NULL
cytokines	NULL
used	NULL
to	NULL
stimulate	NULL
growth	NULL
of	NULL
hematopoietic	NULL
progenitors	NULL
were	NULL
SCF	NULL
,	NULL
IL-6	NULL
,	NULL
IL-3	NULL
,	NULL
and	NULL
EPO	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Representative	NULL
colonies	NULL
(	NULL
day	NULL
7	NULL
)	NULL
showing	NULL
the	NULL
reduction	NULL
in	NULL
size	NULL
of	NULL
WT	NULL
granulocyte	NULL
colonies	NULL
grown	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
9C-RA	NULL
and	NULL
the	NULL
lack	NULL
of	NULL
such	NULL
an	NULL
effect	NULL
in	NULL
RARe~~	NULL
mutants	NULL
.	NULL

RARa	NULL
MODULATES	NULL
GRANULOPOIESIS	NULL
-	NULL
1315	NULL
GR-1	NULL
BMS493	NULL
9C-RA	NULL
ane	NULL
|	NULL
q	NULL
s	NULL
-	NULL
47.6	NULL
WT	NULL
J	NULL
immature	NULL
cells	NULL
(	NULL
gate	NULL
B	NULL
)	NULL
ture	NULL
cells	NULL
%	NULL
7	NULL
52.9	NULL
53.8	NULL
54.1	NULL
ma	NULL
ara	NULL
46.2	NULL
||	NULL
_	NULL
459	NULL
(	NULL
gate	NULL
C	NULL
)	NULL
RARa~/-	NULL
]	NULL
I	NULL
‘	NULL
I	NULL
BMS493	NULL
-	NULL
9C-RA	NULL
Figure	NULL
3	NULL
.	NULL

Accelerated	NULL
differentiation	NULL
of	NULL
RAR	NULL
&	NULL
«	NULL
~~	NULL
granulocytes	NULL
in	NULL
liquid	NULL
cultures	NULL
stimulated	NULL
with	NULL
G-CSF	NULL
and	NULL
SCF	NULL
.	NULL

Cultures	NULL
of	NULL
CFSE-labeled	NULL
BM	NULL
cells	NULL
were	NULL
harvested	NULL
3	NULL
days	NULL
after	NULL
their	NULL
initiation	NULL
and	NULL
stained	NULL
for	NULL
Mac-1	NULL
and	NULL
GR-1	NULL
expression	NULL
.	NULL

The	NULL
RAR	NULL
antagonist	NULL
BMS493	NULL
or	NULL
the	NULL
RXR/RAR	NULL
agonist	NULL
9C-RA	NULL
was	NULL
added	NULL
at	NULL
the	NULL
onset	NULL
of	NULL
the	NULL
culture	NULL
at	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
10-°	NULL
M	NULL
,	NULL
where	NULL
indicated	NULL
.	NULL

(	NULL
A	NULL
)	NULL
The	NULL
analysis	NULL
was	NULL
limited	NULL
to	NULL
CFSE	NULL
``	NULL
cells	NULL
,	NULL
which	NULL
correspond	NULL
to	NULL
cells	NULL
that	NULL
have	NULL
arisen	NULL
during	NULL
the	NULL
culture	NULL
from	NULL
proliferation	NULL
of	NULL
immature	NULL
granulocytes	NULL
.	NULL

Note	NULL
that	NULL
CFSENish	NULL
cells	NULL
correspond	NULL
exclusively	NULL
to	NULL
mature	NULL
granulocytes	NULL
with	NULL
a	NULL
Mac-1	NULL
``	NULL
°	NULL
``	NULL
GR-1	NULL
``	NULL
*	NULL
``	NULL
phenotype	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Representative	NULL
GR-1/Mac-1	NULL
profiles	NULL
of	NULL
CFSE	NULL
``	NULL
cells	NULL
.	NULL

Note	NULL
the	NULL
shift	NULL
toward	NULL
the	NULL
more	NULL
immature	NULL
phenotype	NULL
in	NULL
the	NULL
BMS493-treated	NULL
WT	NULL
sample	NULL
and	NULL
the	NULL
similarity	NULL
of	NULL
the	NULL
phenotypes	NULL
of	NULL
all	NULL
RAR	NULL
«	NULL
~~	NULL
samples	NULL
with	NULL
that	NULL
of	NULL
the	NULL
9C-RA-treated	NULL
WT	NULL
sample	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Quantification	NULL
in	NULL
percent	NULL
of	NULL
all	NULL
cells	NULL
present	NULL
in	NULL
gates	NULL
B	NULL
and	NULL
C	NULL
of	NULL
immature	NULL
(	NULL
gate	NULL
B	NULL
in	NULL
panel	NULL
A	NULL
)	NULL
and	NULL
mature	NULL
(	NULL
gate	NULL
C	NULL
in	NULL
panel	NULL
A	NULL
)	NULL
cells	NULL
from	NULL
the	NULL
experiment	NULL
displayed	NULL
in	NULL
panel	NULL
B	NULL
.	NULL

The	NULL
experiment	NULL
described	NULL
in	NULL
this	NULL
figure	NULL
was	NULL
performed	NULL
in	NULL
duplicate	NULL
for	NULL
each	NULL
of	NULL
the	NULL
2	NULL
WT	NULL
and	NULL
2	NULL
RARe~~	NULL
mice	NULL
.	NULL

For	NULL
a	NULL
given	NULL
set	NULL
of	NULL
culture	NULL
conditions	NULL
and	NULL
mouse	NULL
genotype	NULL
,	NULL
variations	NULL
in	NULL
the	NULL
percentage	NULL
of	NULL
the	NULL
gated	NULL
populations	NULL
were	NULL
within	NULL
1.5	NULL
%	NULL
of	NULL
those	NULL
indicated	NULL
.	NULL

control	NULL
of	NULL
a	NULL
10	NULL
mg/mL	NULL
CFSE	NULL
solution	NULL
in	NULL
dimethyl	NULL
sulfoxide	NULL
followed	NULL
by	NULL
2	NULL
washes	NULL
with	NULL
10	NULL
mL	NULL
medium	NULL
.	NULL

Clonogenic	NULL
cultures	NULL
were	NULL
performed	NULL
with	NULL
commercial	NULL
methylcellulose	NULL
media	NULL
(	NULL
Methocult	NULL
3434	NULL
;	NULL
Stem	NULL
Cell	NULL
Technologies	NULL
,	NULL
Vancou-ver	NULL
,	NULL
BC	NULL
,	NULL
Canada	NULL
)	NULL
.	NULL

The	NULL
media	NULL
contained	NULL
erythropoietin	NULL
(	NULL
EPO	NULL
)	NULL
,	NULL
interleukin-3	NULL
(	NULL
IL-3	NULL
)	NULL
,	NULL
IL-6	NULL
,	NULL
and	NULL
SCF	NULL
for	NULL
the	NULL
experiments	NULL
described	NULL
in	NULL
Figure	NULL
1C	NULL
and	NULL
Figure	NULL
2	NULL
,	NULL
and	NULL
the	NULL
media	NULL
contained	NULL
Methocult	NULL
3234	NULL
supplemented	NULL
with	NULL
granulocyte-macrophage	NULL
(	NULL
GM	NULL
)	NULL
-CSF	NULL
(	NULL
R	NULL
&	NULL
D	NULL
Systems	NULL
)	NULL
at	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
50	NULL
ng/mL	NULL
for	NULL
the	NULL
experiments	NULL
described	NULL
in	NULL
Figure	NULL
4	NULL
.	NULL

Antibodies	NULL
and	NULL
flow	NULL
cytometry	NULL
The	NULL
following	NULL
antibodies	NULL
were	NULL
used	NULL
:	NULL
fluorescein	NULL
isothiocyanate	NULL
(	NULL
FITC	NULL
)	NULL
-labeled	NULL
GR-1	NULL
(	NULL
Caltag	NULL
,	NULL
South	NULL
San	NULL
Francisco	NULL
,	NULL
CA	NULL
)	NULL
or	NULL
phycoerythrin-labeled	NULL
GR-1	NULL
(	NULL
Pharmingen	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
and	NULL
biotin-labeled	NULL
Mac-1	NULL
(	NULL
CD11b	NULL
,	NULL
Pharmingen	NULL
)	NULL
.	NULL

Streptavidin-Cy5	NULL
was	NULL
purchased	NULL
from	NULL
Jackson	NULL
Immunore-search	NULL
Laboratories	NULL
,	NULL
West	NULL
Grove	NULL
,	NULL
PA.	NULL
Antibody	NULL
stainings	NULL
were	NULL
performed	NULL
From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

1316	NULL
_	NULL
KASTNER	NULL
etal	NULL
4	NULL
IK	NULL
promyelocytes	NULL
myelocytes/metamyelocytes	NULL
[	NULL
]	NULL
neutrophils	NULL
day	NULL
5	NULL
50	NULL
30	NULL
20	NULL
10	NULL
0	NULL
owt	NULL
@	NULL
y	NULL
CCI	NULL
&	NULL
&	NULL
``	NULL
$	NULL
¢	NULL
&	NULL
8	NULL
,	NULL
®	NULL
T	NULL
Hts	NULL
a	NULL
§§	NULL
[	NULL
<	NULL
a	NULL
&	NULL
se	NULL
?	NULL

@	NULL
1,3	NULL
;	NULL
t	NULL
;	NULL
&	NULL
oC	NULL
0	NULL
a*	NULL
day	NULL
8	NULL
<	NULL
%	NULL
+	NULL
%	NULL
f	NULL
f	NULL
,	NULL
*	NULL
:	NULL
’	NULL
``	NULL
\	NULL
C	NULL
in	NULL
f	NULL
&	NULL
t	NULL
K	NULL
es	NULL
&	NULL
.	NULL

K	NULL
A	NULL
a	NULL
'	NULL
*	NULL
a	NULL
4	NULL
~	NULL
*	NULL
®	NULL
4	NULL
*	NULL
.	NULL

on	NULL
105	NULL
BM	NULL
or	NULL
FL	NULL
cells	NULL
and	NULL
analyzed	NULL
(	NULL
Coulter	NULL
Elite	NULL
cytometer	NULL
;	NULL
Coulter	NULL
Electronics	NULL
,	NULL
Hialeah	NULL
,	NULL
FL	NULL
)	NULL
.	NULL

Listmode	NULL
data	NULL
were	NULL
collected	NULL
on	NULL
3	NULL
X	NULL
10+	NULL
cells	NULL
.	NULL

Reverse	NULL
transcriptase-PCR	NULL
Reverse	NULL
transcriptase	NULL
(	NULL
RT	NULL
)	NULL
-PCR	NULL
reactions	NULL
were	NULL
performed	NULL
on	NULL
50	NULL
ng	NULL
complementary	NULL
DNA	NULL
(	NULL
cDNA	NULL
)	NULL
using	NULL
the	NULL
following	NULL
oligonucleotides	NULL
:	NULL
cathepsin	NULL
G	NULL
:	NULL
5-GATTGTAATCAGGATGGCGG-3	NULL
'	NULL
,	NULL
5'-CTGACTAAG-CAACGGTTCTGG-3	NULL
'	NULL
;	NULL
myeloperoxidase	NULL
:	NULL
5'-ATGCAGTGGGGA-CAGTTTCTG-3	NULL
'	NULL
,	NULL
5-GTCGTTGTAGGATCGGTACTG-3	NULL
'	NULL
;	NULL
elastase	NULL
:	NULL
5'-CACCATCAGTCAGGTCTTCC-3	NULL
'	NULL
,	NULL
5'-AGTCTCCGAAGCATATGCC-3	NULL
'	NULL
;	NULL
B-actin	NULL
:	NULL
5-GTGACGAGGCCCAGAGCAAGAG-3	NULL
'	NULL
,	NULL
5-AGGGGC-CGGACTCATCGTACTC-3	NULL
'	NULL
;	NULL
RARB	NULL
:	NULL
5'-CTCGTCCCGAGCCCACCA-TCTCCACTT-3	NULL
'	NULL
,	NULL
5	NULL
-GAGGTCGTCTAGCTCCGCTGTCATCTC-3	NULL
'	NULL
;	NULL
and	NULL
hypoxanthine	NULL
phosphoribosyltransferase	NULL
(	NULL
HPRT	NULL
)	NULL
:	NULL
5'-GTAATGATCAGT-CAACG-3	NULL
'	NULL
,	NULL
5-CCAGCAAGCTTGCAACCTTAACCA-3	NULL
'	NULL
.	NULL

RARRB	NULL
and	NULL
HPRT	NULL
amplification	NULL
products	NULL
(	NULL
Figure	NULL
1D	NULL
)	NULL
were	NULL
detected	NULL
after	NULL
Southern	NULL
blot	NULL
analysis	NULL
and	NULL
hybridization	NULL
with	NULL
phosphorous	NULL
32	NULL
(	NULL
*P	NULL
)	NULL
-labeled	NULL
oligonucleotide	NULL
probes	NULL
(	NULL
5'-CCATAGTGGTAGCC-3	NULL
'	NULL
and	NULL
5-CACTGG-TAAAACAATGCAAA-3	NULL
'	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

Results	NULL
RARs	NULL
are	NULL
dispensable	NULL
for	NULL
granulopoiesis	NULL
Granulocyte	NULL
populations	NULL
appeared	NULL
normal	NULL
in	NULL
RARa	NULL
«	NULL
~'~	NULL
mice	NULL
at	NULL
the	NULL
level	NULL
of	NULL
blood	NULL
neutrophil	NULL
counts	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
and	NULL
in	NULL
the	NULL
BM	NULL
(	NULL
GR-1*Mac-1*	NULL
population	NULL
;	NULL
Figure	NULL
5C	NULL
,	NULL
upper	NULL
right	NULL
panel	NULL
,	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
investigate	NULL
whether	NULL
functional	NULL
compensation	NULL
by	NULL
other	NULL
RARs	NULL
occurs	NULL
in	NULL
RARa	NULL
«	NULL
~'~	NULL
mutants	NULL
,	NULL
we	NULL
examined	NULL
RARa~-RARy~'~-	NULL
double	NULL
mutants	NULL
,	NULL
as	NULL
RARy	NULL
is	NULL
also	NULL
expressed	NULL
in	NULL
granulocytes	NULL
.	NULL
``	NULL

Because	NULL
RARa~-RARy~~-	NULL
mutants	NULL
die	NULL
in	NULL
utero	NULL
,	NULL
``	NULL
``	NULL
granulopoiesis	NULL
was	NULL
studied	NULL
in	NULL
the	NULL
FL	NULL
.	NULL

Granulocytes	NULL
BLOOD	NULL
,	NULL
1	NULL
MARCH	NULL
2001	NULL
«	NULL
VOLUME	NULL
97	NULL
,	NULL
NUMBER	NULL
5	NULL
Figure	NULL
4	NULL
.	NULL

Accelerated	NULL
differentiation	NULL
of	NULL
granulocytes	NULL
in	NULL
GM-CSF-dependent	NULL
clonogenic	NULL
cul-tures	NULL
.	NULL

We	NULL
plated	NULL
5	NULL
x	NULL
10	NULL
%	NULL
BM	NULL
cells	NULL
in	NULL
methylcellulose	NULL
|	NULL
medium	NULL
containing	NULL
50	NULL
ng/mL	NULL
GM-CSF	NULL
.	NULL

(	NULL
A-D	NULL
)	NULL
Pooled	NULL
cells	NULL
from	NULL
all	NULL
the	NULL
colonies	NULL
developing	NULL
on	NULL
a	NULL
dish	NULL
(	NULL
about	NULL
70	NULL
colonies	NULL
)	NULL
were	NULL
cytocentrifuged	NULL
onto	NULL
a	NULL
glass	NULL
slide	NULL
and	NULL
stained	NULL
with	NULL
May-Grinwald-Giemsa	NULL
.	NULL

Arrowheads	NULL
in	NULL
panel	NULL
A	NULL
indicate	NULL
promyelocytes	NULL
that	NULL
are	NULL
numerous	NULL
on	NULL
slides	NULL
-	NULL
from	NULL
day-5	NULL
WT	NULL
cultures	NULL
,	NULL
but	NULL
are	NULL
less	NULL
frequent	NULL
in	NULL
mutant	NULL
samples	NULL
.	NULL

The	NULL
inset	NULL
in	NULL
panels	NULL
A	NULL
and	NULL
B	NULL
corresponds	NULL
to	NULL
the	NULL
scoring	NULL
of	NULL
approximately	NULL
400	NULL
cells	NULL
of	NULL
the	NULL
granulocyte	NULL
lineage	NULL
for	NULL
each	NULL
case	NULL
.	NULL

(	NULL
E	NULL
,	NULL
F	NULL
)	NULL
Typical	NULL
colonies	NULL
from	NULL
culture	NULL
dishes	NULL
at	NULL
day	NULL
8	NULL
;	NULL
note	NULL
the	NULL
reduction	NULL
in	NULL
the	NULL
number	NULL
and	NULL
size	NULL
of	NULL
dense	NULL
cellular	NULL
aggregates	NULL
(	NULL
arrows	NULL
)	NULL
}	NULL
,	NULL
which	NULL
correspond	NULL
to	NULL
granulocytes	NULL
.	NULL

developed	NULL
normally	NULL
in	NULL
RARa	NULL
«	NULL
~-RARy~~-	NULL
E14.5	NULL
FLs	NULL
as	NULL
tested	NULL
by	NULL
several	NULL
criteria	NULL
:	NULL
double-mutant	NULL
myeloid	NULL
cells	NULL
exhibited	NULL
a	NULL
normal	NULL
GR-1+*Mac-1*	NULL
phenotype	NULL
(	NULL
Figure	NULL
1A	NULL
)	NULL
;	NULL
differentiated	NULL
cells	NULL
(	NULL
containing	NULL
ring-shaped	NULL
or	NULL
segmented	NULL
nuclei	NULL
)	NULL
were	NULL
detected	NULL
at	NULL
similar	NULL
frequencies	NULL
on	NULL
cytospin	NULL
preparations	NULL
from	NULL
mutant	NULL
and	NULL
WT	NULL
FLs	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
;	NULL
granulocyte-specific	NULL
markers	NULL
were	NULL
expressed	NULL
at	NULL
similar	NULL
levels	NULL
(	NULL
Figure	NULL
1B	NULL
)	NULL
;	NULL
and	NULL
morphologically	NULL
normal	NULL
neutrophils	NULL
were	NULL
generated	NULL
in	NULL
myeloid	NULL
colonies	NULL
in	NULL
vitro	NULL
(	NULL
Figure	NULL
1C	NULL
)	NULL
.	NULL

Because	NULL
RARBG	NULL
expression	NULL
was	NULL
not	NULL
detected	NULL
in	NULL
freshly	NULL
isolated	NULL
or	NULL
cultured	NULL
FL	NULL
cells	NULL
(	NULL
Figure	NULL
1D	NULL
)	NULL
,	NULL
granulopoiesis	NULL
can	NULL
thus	NULL
proceed	NULL
efficiently	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
any	NULL
RAR	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
granulocyte	NULL
progenitors	NULL
from	NULL
RARa~	NULL
'	NULL
mice	NULL
could	NULL
still	NULL
respond	NULL
to	NULL
retinoids	NULL
,	NULL
we	NULL
compared	NULL
the	NULL
response	NULL
of	NULL
WT	NULL
and	NULL
RARa~~-	NULL
BM	NULL
cells	NULL
to	NULL
9-cis	NULL
retinoic	NULL
acid	NULL
(	NULL
IC-RA	NULL
,	NULL
a	NULL
pan-RAR	NULL
and	NULL
pan-RXR	NULL
[	NULL
retinoid	NULL
X	NULL
receptor	NULL
]	NULL
agonist	NULL
)	NULL
in	NULL
a	NULL
myeloid	NULL
colony-forming	NULL
assay	NULL
.	NULL

As	NULL
previously	NULL
reported	NULL
,	NULL
``	NULL
``	NULL
the	NULL
total	NULL
number	NULL
of	NULL
colonies	NULL
developing	NULL
from	NULL
WT	NULL
BM	NULL
cells	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
size	NULL
of	NULL
pure	NULL
granulocyte	NULL
colonies	NULL
,	NULL
were	NULL
markedly	NULL
reduced	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
9C-RA	NULL
(	NULL
Figure	NULL
2A	NULL
,	NULL
B	NULL
)	NULL
.	NULL

Neither	NULL
of	NULL
these	NULL
effects	NULL
were	NULL
observed	NULL
in	NULL
cultures	NULL
of	NULL
RARa~	NULL
``	NULL
~	NULL
BM	NULL
cells	NULL
(	NULL
Figure	NULL
2	NULL
)	NULL
(	NULL
P	NULL
<	NULL
.01	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
RARa~'~	NULL
granulocyte	NULL
progenitors	NULL
are	NULL
impaired	NULL
in	NULL
their	NULL
response	NULL
to	NULL
retinoids	NULL
.	NULL

These	NULL
results	NULL
,	NULL
together	NULL
with	NULL
the	NULL
apparent	NULL
normal	NULL
granulopoiesis	NULL
in	NULL
RARa	NULL
«	NULL
~-RARy~~-	NULL
mutants	NULL
,	NULL
demonstrate	NULL
that	NULL
RARs	NULL
and	NULL
retinoids	NULL
are	NULL
dispensable	NULL
for	NULL
granulopoiesis	NULL
.	NULL

Accelerated	NULL
granulocyte	NULL
differentiation	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
RARe	NULL
«	NULL
Although	NULL
the	NULL
RA/RAR	NULL
pathway	NULL
is	NULL
not	NULL
required	NULL
,	NULL
it	NULL
can	NULL
clearly	NULL
modulate	NULL
granulocyte	NULL
differentiation	NULL
,	NULL
as	NULL
shown	NULL
by	NULL
the	NULL
response	NULL
of	NULL
WT	NULL
cells	NULL
to	NULL
retinoids	NULL
.	NULL

Consequently	NULL
,	NULL
we	NULL
analyzed	NULL
the	NULL
effects	NULL
of	NULL
RAR	NULL
agonists	NULL
and	NULL
antagonists	NULL
on	NULL
granulocyte	NULL
differentiation	NULL
in	NULL
From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

BLOOD	NULL
,	NULL
1	NULL
MARCH	NULL
2001	NULL
»	NULL
VOLUME	NULL
97	NULL
,	NULL
NUMBER	NULL
5	NULL
B	NULL
CRapi+/+	NULL
chapi~-	NULL
``	NULL
_	NULL
VAD	NULL
diet	NULL
'	NULL
!	NULL

Control	NULL
diet	NULL
VAD	NULL
diet	NULL
'	NULL
p-	NULL
r	NULL
ars	NULL
%	NULL
Figure	NULL
5	NULL
.	NULL

Effect	NULL
of	NULL
retinoid	NULL
excess	NULL
and	NULL
VAD	NULL
on	NULL
granulopoiesis	NULL
in	NULL
vivo	NULL
.	NULL

BM	NULL
granulocyte	NULL
populations	NULL
were	NULL
analyzed	NULL
by	NULL
flow	NULL
cytometry	NULL
with	NULL
the	NULL
Mac-1	NULL
and	NULL
GR-1	NULL
markers	NULL
.	NULL

Granulocyte	NULL
differentiation	NULL
proceeds	NULL
along	NULL
a	NULL
curve-shaped	NULL
path	NULL
in	NULL
which	NULL
increasing	NULL
levels	NULL
of	NULL
Mac-1	NULL
and	NULL
GR-1	NULL
are	NULL
acquired	NULL
as	NULL
the	NULL
cells	NULL
mature	NULL
.	NULL

Thus	NULL
,	NULL
Mac-1°®~GR-1°*	NULL
cells	NULL
correspond	NULL
mainly	NULL
to	NULL
promyelocytes	NULL
,	NULL
myelocytes	NULL
,	NULL
and	NULL
metamyelocytes	NULL
,	NULL
whereas	NULL
Mac-1*GR-1	NULL
``	NULL
*	NULL
``	NULL
cells	NULL
correspond	NULL
mainly	NULL
to	NULL
band	NULL
and	NULL
segmented	NULL
neutrophils®	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

(	NULL
A	NULL
)	NULL
WT	NULL
mice	NULL
were	NULL
treated	NULL
for	NULL
3	NULL
days	NULL
with	NULL
10	NULL
mg/kg	NULL
BMS493	NULL
or	NULL
vehicle	NULL
.	NULL

In	NULL
the	NULL
right	NULL
panels	NULL
the	NULL
GR-1	NULL
profile	NULL
of	NULL
the	NULL
granulocyte	NULL
population	NULL
(	NULL
Mac-1*	NULL
cells	NULL
,	NULL
gated	NULL
in	NULL
the	NULL
left	NULL
panels	NULL
)	NULL
is	NULL
shown	NULL
,	NULL
and	NULL
the	NULL
percentage	NULL
of	NULL
GR-1	NULL
``	NULL
*	NULL
immature	NULL
granulocytes	NULL
within	NULL
that	NULL
population	NULL
is	NULL
indicated	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Granulocyte	NULL
populations	NULL
in	NULL
VAD	NULL
mice	NULL
.	NULL

Note	NULL
the	NULL
overall	NULL
increase	NULL
of	NULL
the	NULL
granulocyte	NULL
population	NULL
{	NULL
gated	NULL
in	NULL
the	NULL
top	NULL
panels	NULL
)	NULL
and	NULL
the	NULL
increase	NULL
,	NULL
within	NULL
that	NULL
population	NULL
,	NULL
of	NULL
the	NULL
immature	NULL
granulocyte	NULL
population	NULL
(	NULL
GR-1	NULL
``	NULL
**	NULL
cells	NULL
,	NULL
bottom	NULL
panels	NULL
)	NULL
that	NULL
occurs	NULL
specifically	NULL
in	NULL
the	NULL
VAD	NULL
mice	NULL
(	NULL
ie	NULL
,	NULL
CRBPI~'~	NULL
mice	NULL
fed	NULL
a	NULL
VAD	NULL
diet	NULL
)	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Effect	NULL
of	NULL
ATRA	NULL
administration	NULL
.	NULL

Mice	NULL
were	NULL
treated	NULL
with	NULL
100	NULL
mg/kg	NULL
ATRA	NULL
or	NULL
vehicle	NULL
for	NULL
72	NULL
hours	NULL
.	NULL

Note	NULL
the	NULL
shift	NULL
to	NULL
the	NULL
right	NULL
of	NULL
GR-1	NULL
expression	NULL
within	NULL
the	NULL
immature	NULL
granulocyte	NULL
population	NULL
(	NULL
gated	NULL
)	NULL
in	NULL
AT	NULL
RA-treated	NULL
WT	NULL
mice	NULL
,	NULL
producing	NULL
a	NULL
comet-like	NULL
profile	NULL
,	NULL
which	NULL
is	NULL
not	NULL
seen	NULL
in	NULL
the	NULL
ATRA-treated	NULL
RARa~~	NULL
mice	NULL
.	NULL

Note	NULL
that	NULL
a	NULL
reduction	NULL
in	NULL
the	NULL
number	NULL
of	NULL
the	NULL
mature	NULL
(	NULL
GR-1	NULL
``	NULL
%	NULL
``	NULL
)	NULL
BM	NULL
granulocytes	NULL
was	NULL
also	NULL
observed	NULL
in	NULL
ATRA-treated	NULL
WT	NULL
mice	NULL
,	NULL
which	NULL
probably	NULL
reflects	NULL
an	NULL
enhanced	NULL
efflux	NULL
of	NULL
neutrophils	NULL
from	NULL
the	NULL
BM	NULL
,	NULL
as	NULL
peripheral	NULL
blood	NULL
neutrophil	NULL
numbers	NULL
were	NULL
increased	NULL
1.5-	NULL
to	NULL
3-fold	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

liquid	NULL
cultures	NULL
of	NULL
WT	NULL
BM	NULL
cells	NULL
stimulated	NULL
with	NULL
G-CSF	NULL
and	NULL
SCF	NULL
.	NULL

To	NULL
monitor	NULL
cells	NULL
that	NULL
had	NULL
undergone	NULL
division	NULL
during	NULL
the	NULL
culture	NULL
period	NULL
,	NULL
freshly	NULL
isolated	NULL
BM	NULL
cells	NULL
were	NULL
cytoplasmically	NULL
labeled	NULL
with	NULL
the	NULL
vital	NULL
dye	NULL
CFSE	NULL
(	NULL
a	NULL
fluorescent	NULL
compound	NULL
that	NULL
is	NULL
gradually	NULL
diluted	NULL
upon	NULL
cell	NULL
division	NULL
)	NULL
prior	NULL
to	NULL
culture	NULL
,	NULL
and	NULL
analysis	NULL
was	NULL
confined	NULL
to	NULL
CFSE-**	NULL
cells	NULL
(	NULL
Figure	NULL
3A	NULL
)	NULL
.	NULL

Increased	NULL
levels	NULL
of	NULL
GR-1	NULL
and	NULL
Mac-1	NULL
expression	NULL
were	NULL
used	NULL
to	NULL
measure	NULL
differentiation	NULL
.	NULL
``	NULL

''	NULL
9C-RA	NULL
induced	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
proportion	NULL
of	NULL
de	NULL
novo	NULL
GR-1	NULL
``	NULL
®	NULL
``	NULL
cells	NULL
in	NULL
cultures	NULL
of	NULL
WT	NULL
cells	NULL
(	NULL
Figure	NULL
3B	NULL
,	NULL
upper	NULL
right	NULL
panel	NULL
,	NULL
gate	NULL
C	NULL
,	NULL
and	NULL
Figure	NULL
3C	NULL
)	NULL
as	NULL
well	NULL
as	NULL
a	NULL
decrease	NULL
in	NULL
the	NULL
proportion	NULL
of	NULL
CFSE	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
which	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
premise	NULL
that	NULL
RA	NULL
limits	NULL
the	NULL
proliferation	NULL
of	NULL
granulocyte	NULL
precursors	NULL
and	NULL
induces	NULL
their	NULL
differentiation	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
pan-RAR	NULL
antagonist	NULL
BMS493	NULL
(	NULL
H.	NULL
Gronemeyer	NULL
and	NULL
PC	NULL
.	NULL

,	NULL
unpublished	NULL
observation	NULL
,	NULL
February	NULL
1996	NULL
)	NULL
induced	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
proportion	NULL
of	NULL
immature	NULL
granulocytes	NULL
(	NULL
Figure	NULL
3B	NULL
,	NULL
upper	NULL
middle	NULL
panel	NULL
,	NULL
gate	NULL
B	NULL
,	NULL
and	NULL
Figure	NULL
3C	NULL
)	NULL
,	NULL
a	NULL
finding	NULL
corroborated	NULL
by	NULL
the	NULL
higher	NULL
frequency	NULL
of	NULL
promyelocytes/myelocytes	NULL
on	NULL
cytospin	NULL
preparations	NULL
from	NULL
these	NULL
cultures	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
magnitude	NULL
of	NULL
the	NULL
response	NULL
to	NULL
BMS493	NULL
greatly	NULL
exceeded	NULL
that	NULL
to	NULL
9C-RA	NULL
,	NULL
suggesting	NULL
that	NULL
retinoids	NULL
in	NULL
the	NULL
serum	NULL
might	NULL
play	NULL
an	NULL
important	NULL
part	NULL
in	NULL
controlling	NULL
the	NULL
differentiation	NULL
that	NULL
occurs	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
exogenous	NULL
ligands	NULL
.	NULL

When	NULL
RARa~'~	NULL
BM	NULL
cells	NULL
were	NULL
grown	NULL
under	NULL
identical	NULL
culture	NULL
conditions	NULL
,	NULL
the	NULL
ratio	NULL
of	NULL
immature	NULL
RARa	NULL
MODULATES	NULL
GRANULOPOIESIS	NULL
-	NULL
1317	NULL
versus	NULL
mature	NULL
cells	NULL
generated	NULL
was	NULL
unaffected	NULL
by	NULL
treatment	NULL
with	NULL
either	NULL
IC-RA	NULL
or	NULL
BMS493	NULL
(	NULL
Figure	NULL
3B	NULL
,	NULL
C	NULL
)	NULL
,	NULL
confirming	NULL
the	NULL
resistance	NULL
of	NULL
RARa	NULL
«	NULL
~-	NULL
granulocytes	NULL
to	NULL
the	NULL
effects	NULL
of	NULL
RAR	NULL
ligands	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
proportions	NULL
of	NULL
mature	NULL
cells	NULL
were	NULL
consistently	NULL
increased	NULL
when	NULL
compared	NULL
with	NULL
WT	NULL
samples	NULL
in	NULL
the	NULL
control	NULL
and	NULL
BMS493-treated	NULL
cultures	NULL
to	NULL
levels	NULL
usually	NULL
observed	NULL
in	NULL
9C-RA-treated	NULL
WT	NULL
cultures	NULL
(	NULL
Figure	NULL
3B	NULL
,	NULL
C	NULL
)	NULL
.	NULL

Thus	NULL
granulocyte	NULL
differentiation	NULL
appears	NULL
to	NULL
be	NULL
accelerated	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
RARa	NULL
.	NULL

This	NULL
apparent	NULL
acceleration	NULL
of	NULL
maturation	NULL
was	NULL
also	NULL
seen	NULL
in	NULL
clonogenic	NULL
methylcellulose	NULL
cultures	NULL
stimulated	NULL
with	NULL
GM-CSF	NULL
(	NULL
Figure	NULL
4	NULL
)	NULL
.	NULL

After	NULL
5	NULL
days	NULL
of	NULL
culture	NULL
,	NULL
granulocytes	NULL
from	NULL
pooled	NULL
RARa~	NULL
``	NULL
~	NULL
colonies	NULL
were	NULL
more	NULL
mature	NULL
than	NULL
those	NULL
from	NULL
WT	NULL
colonies	NULL
(	NULL
compare	NULL
Figure	NULL
4A	NULL
with	NULL
B	NULL
and	NULL
inset	NULL
)	NULL
.	NULL

By	NULL
day	NULL
8	NULL
,	NULL
there	NULL
was	NULL
a	NULL
marked	NULL
underrepresentation	NULL
of	NULL
granulocytes	NULL
in	NULL
the	NULL
mutant	NULL
cultures	NULL
,	NULL
which	NULL
now	NULL
consisted	NULL
mainly	NULL
of	NULL
macrophages	NULL
(	NULL
Figure	NULL
4C	NULL
,	NULL
D	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
prematurely	NULL
differentiated	NULL
neutrophils	NULL
seen	NULL
on	NULL
day	NULL
5	NULL
of	NULL
culture	NULL
had	NULL
died	NULL
off	NULL
over	NULL
time	NULL
.	NULL

At	NULL
the	NULL
colony	NULL
level	NULL
,	NULL
dense	NULL
granulocyte	NULL
clusters	NULL
were	NULL
less	NULL
abundant	NULL
and	NULL
smaller	NULL
in	NULL
RARa~'~-cultures	NULL
after	NULL
8	NULL
days	NULL
(	NULL
Figure	NULL
4E	NULL
,	NULL
F	NULL
)	NULL
,	NULL
a	NULL
phenotype	NULL
that	NULL
reliably	NULL
allowed	NULL
for	NULL
the	NULL
blind	NULL
separation	NULL
of	NULL
dishes	NULL
containing	NULL
WT	NULL
or	NULL
RARa~~	NULL
cells	NULL
.	NULL

It	NULL
is	NULL
noteworthy	NULL
that	NULL
both	NULL
types	NULL
of	NULL
experimental	NULL
cultures	NULL
used	NULL
different	NULL
cytokines	NULL
(	NULL
G-CSF	NULL
and	NULL
SCF	NULL
for	NULL
the	NULL
liquid	NULL
cultures	NULL
and	NULL
GM-CSF	NULL
for	NULL
the	NULL
methylcellulose	NULL
cultures	NULL
)	NULL
,	NULL
thus	NULL
excluding	NULL
a	NULL
cytokine-specific	NULL
effect	NULL
.	NULL

These	NULL
observations	NULL
provide	NULL
evidence	NULL
that	NULL
lack	NULL
of	NULL
RARa	NULL
relieves	NULL
a	NULL
physiological	NULL
restraint	NULL
on	NULL
granulocyte	NULL
differentiation	NULL
normally	NULL
exerted	NULL
by	NULL
this	NULL
receptor	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
ligand	NULL
.	NULL

Retinoids	NULL
control	NULL
granulopoiesis	NULL
in	NULL
vivo	NULL
To	NULL
understand	NULL
how	NULL
retinoids	NULL
may	NULL
modulate	NULL
granulopoiesis	NULL
in	NULL
vivo	NULL
,	NULL
we	NULL
evaluated	NULL
granulocyte	NULL
differentiation	NULL
in	NULL
WT	NULL
mice	NULL
treated	NULL
with	NULL
BMS493	NULL
.	NULL

Of	NULL
11	NULL
treated	NULL
WT	NULL
mice	NULL
,	NULL
7	NULL
mice	NULL
exhibited	NULL
a	NULL
clear	NULL
increase	NULL
in	NULL
the	NULL
proportion	NULL
of	NULL
immature	NULL
granulocytes	NULL
in	NULL
the	NULL
BM	NULL
(	NULL
Mac-1	NULL
!	NULL

°+GR-1-	NULL
``	NULL
°*	NULL
,	NULL
Figure	NULL
5A	NULL
)	NULL
.	NULL

As	NULL
this	NULL
increase	NULL
was	NULL
not	NULL
seen	NULL
in	NULL
vehicle-treated	NULL
or	NULL
untreated	NULL
animals	NULL
,	NULL
its	NULL
occurrence	NULL
in	NULL
BMS493-treated	NULL
mice	NULL
most	NULL
likely	NULL
reflects	NULL
a	NULL
role	NULL
for	NULL
endogenous	NULL
retinoids	NULL
in	NULL
regulating	NULL
granulocyte	NULL
differentiation	NULL
.	NULL

To	NULL
investigate	NULL
further	NULL
,	NULL
we	NULL
analyzed	NULL
VAD	NULL
mice	NULL
using	NULL
CRBPI-deficient	NULL
mice	NULL
that	NULL
,	NULL
owing	NULL
to	NULL
low	NULL
vitamin	NULL
A	NULL
stores	NULL
,	NULL
become	NULL
readily	NULL
VAD	NULL
when	NULL
starved	NULL
for	NULL
vitamin	NULL
A	NULL
.	NULL
``	NULL

''	NULL
In	NULL
all	NULL
VAD	NULL
CRBPI	NULL
--	NULL
mice	NULL
tested	NULL
(	NULL
n	NULL
=	NULL
6	NULL
)	NULL
,	NULL
there	NULL
was	NULL
a	NULL
marked	NULL
expansion	NULL
in	NULL
the	NULL
size	NULL
of	NULL
the	NULL
entire	NULL
granulocyte	NULL
population	NULL
(	NULL
Figure	NULL
5B	NULL
,	NULL
upper	NULL
right	NULL
panel	NULL
)	NULL
when	NULL
compared	NULL
with	NULL
control	NULL
animals	NULL
(	NULL
ie	NULL
,	NULL
CRBPI~'-	NULL
mice	NULL
on	NULL
a	NULL
normal	NULL
diet	NULL
or	NULL
CRBPI+*'*	NULL
mice	NULL
on	NULL
a	NULL
VAD	NULL
diet	NULL
)	NULL
as	NULL
well	NULL
as	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
proportion	NULL
of	NULL
immature	NULL
Mac-1'°*+GR-1-/°w	NULL
cells	NULL
(	NULL
Figure	NULL
5B	NULL
,	NULL
lower	NULL
right	NULL
panel	NULL
)	NULL
.	NULL

This	NULL
effect	NULL
was	NULL
accompanied	NULL
by	NULL
an	NULL
increase	NULL
of	NULL
neutrophils	NULL
in	NULL
the	NULL
spleen	NULL
and	NULL
blood	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
which	NULL
is	NULL
consistent	NULL
with	NULL
a	NULL
previous	NULL
report	NULL
showing	NULL
enhanced	NULL
neutrophil	NULL
numbers	NULL
in	NULL
VAD	NULL
rats	NULL
.	NULL
``	NULL

Importantly	NULL
,	NULL
the	NULL
VAD-induced	NULL
increase	NULL
in	NULL
the	NULL
immature	NULL
granulocyte	NULL
compartment	NULL
of	NULL
the	NULL
BM	NULL
mirrors	NULL
that	NULL
seen	NULL
following	NULL
BMS493	NULL
administration	NULL
(	NULL
Figure	NULL
5A	NULL
)	NULL
,	NULL
underscoring	NULL
a	NULL
role	NULL
for	NULL
endogenous	NULL
retinoids	NULL
in	NULL
the	NULL
positive	NULL
control	NULL
of	NULL
granulopoiesis	NULL
in	NULL
vivo	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
ATRA	NULL
treatment	NULL
of	NULL
WT	NULL
mice	NULL
(	NULL
n	NULL
=	NULL
7	NULL
)	NULL
elicited	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
levels	NULL
of	NULL
GR-1	NULL
and	NULL
Mac-1	NULL
expressed	NULL
by	NULL
the	NULL
Mac-1°*~*GR-1~	NULL
``	NULL
**	NULL
immature	NULL
granulocyte	NULL
population	NULL
(	NULL
Figure	NULL
5C	NULL
,	NULL
gated	NULL
region	NULL
,	NULL
compare	NULL
upper	NULL
and	NULL
lower	NULL
left	NULL
panels	NULL
)	NULL
,	NULL
an	NULL
effect	NULL
that	NULL
did	NULL
not	NULL
occur	NULL
in	NULL
RARa~~	NULL
mice	NULL
(	NULL
n	NULL
=	NULL
4	NULL
)	NULL
(	NULL
Figure	NULL
5C	NULL
,	NULL
right	NULL
panels	NULL
)	NULL
.	NULL

This	NULL
indicates	NULL
that	NULL
RARa	NULL
is	NULL
the	NULL
direct	NULL
mediator	NULL
of	NULL
exogenous	NULL
(	NULL
and	NULL
,	NULL
by	NULL
inference	NULL
,	NULL
endogenous	NULL
)	NULL
retinoid-induced	NULL
differentiation	NULL
.	NULL

Signifi-cantly	NULL
,	NULL
the	NULL
fact	NULL
that	NULL
all	NULL
7	NULL
ATRA-treated	NULL
WT	NULL
mice	NULL
responded	NULL
in	NULL
a	NULL
similar	NULL
manner	NULL
also	NULL
suggests	NULL
that	NULL
under	NULL
normal	NULL
dietary	NULL
conditions	NULL
,	NULL
From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

1318	NULL
-	NULL
KASTNER	NULL
etal	NULL
RARa	NULL
proteins	NULL
are	NULL
not	NULL
fully	NULL
liganded	NULL
in	NULL
vivo	NULL
,	NULL
thus	NULL
placing	NULL
them	NULL
in	NULL
an	NULL
appropriate	NULL
state	NULL
to	NULL
negatively	NULL
regulate	NULL
differentiation	NULL
.	NULL

Discussion	NULL
RARa	NULL
«	NULL
:	NULL
a	NULL
bidirectional	NULL
modulator	NULL
of	NULL
granulopoiesis	NULL
We	NULL
have	NULL
shown	NULL
here	NULL
that	NULL
(	NULL
1	NULL
)	NULL
endogenous	NULL
RARa	NULL
«	NULL
is	NULL
a	NULL
key	NULL
mediator	NULL
of	NULL
the	NULL
effects	NULL
of	NULL
retinoids	NULL
on	NULL
granulopoiesis	NULL
,	NULL
and	NULL
(	NULL
2	NULL
)	NULL
the	NULL
RARa	NULL
receptor	NULL
can	NULL
bidirectionally	NULL
modulate	NULL
granulopoiesis	NULL
as	NULL
a	NULL
differentiation	NULL
factor	NULL
when	NULL
liganded	NULL
to	NULL
RA	NULL
or	NULL
as	NULL
an	NULL
inhibitor	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
ligand	NULL
(	NULL
or	NULL
when	NULL
liganded	NULL
to	NULL
an	NULL
antagonist	NULL
)	NULL
,	NULL
probably	NULL
by	NULL
acting	NULL
as	NULL
a	NULL
transcriptional	NULL
repressor	NULL
.	NULL

``	NULL
>	NULL
>	NULL
The	NULL
fact	NULL
that	NULL
RA	NULL
is	NULL
a	NULL
differentiating	NULL
agent	NULL
for	NULL
granulocytes	NULL
in	NULL
culture	NULL
has	NULL
been	NULL
well	NULL
established	NULL
for	NULL
both	NULL
normal	NULL
and	NULL
leukemic	NULL
However	NULL
,	NULL
the	NULL
role	NULL
of	NULL
retinoids	NULL
during	NULL
normal	NULL
granulocyte	NULL
differentiation	NULL
in	NULL
vivo	NULL
has	NULL
so	NULL
far	NULL
not	NULL
been	NULL
documented	NULL
.	NULL

The	NULL
increase	NULL
in	NULL
the	NULL
immature	NULL
granulocyte	NULL
populations	NULL
,	NULL
seen	NULL
both	NULL
in	NULL
the	NULL
VAD	NULL
and	NULL
BMS493-treated	NULL
mice	NULL
here	NULL
,	NULL
show	NULL
for	NULL
the	NULL
first	NULL
time	NULL
that	NULL
retinoid-controlled	NULL
differentiation	NULL
actively	NULL
contributes	NULL
to	NULL
the	NULL
regulation	NULL
of	NULL
granulocyte	NULL
numbers	NULL
in	NULL
vivo	NULL
.	NULL

Our	NULL
VAD	NULL
results	NULL
are	NULL
in	NULL
agreement	NULL
with	NULL
those	NULL
of	NULL
Kuwata	NULL
et	NULL
al	NULL
,	NULL
``	NULL
``	NULL
who	NULL
recently	NULL
reported	NULL
a	NULL
collective	NULL
increase	NULL
in	NULL
granulocyte	NULL
numbers	NULL
during	NULL
murine	NULL
VAD	NULL
as	NULL
well	NULL
as	NULL
with	NULL
an	NULL
earlier	NULL
report	NULL
documenting	NULL
elevated	NULL
neutrophils	NULL
in	NULL
the	NULL
peripheral	NULL
blood	NULL
of	NULL
VAD	NULL
rats	NULL
.	NULL
``	NULL

Although	NULL
Kuwata	NULL
et	NULL
al	NULL
``	NULL
``	NULL
did	NULL
not	NULL
study	NULL
the	NULL
relative	NULL
contributions	NULL
of	NULL
immature	NULL
versus	NULL
mature	NULL
cells	NULL
in	NULL
their	NULL
granulocyte	NULL
population	NULL
,	NULL
their	NULL
VAD	NULL
mice	NULL
also	NULL
seemed	NULL
to	NULL
accumulate	NULL
more	NULL
cells	NULL
with	NULL
a	NULL
GR-1'°*	NULL
phenotype	NULL
,	NULL
as	NULL
seen	NULL
in	NULL
the	NULL
Kuwata	NULL
et	NULL
al	NULL
Figure	NULL
3A	NULL
,	NULL
``	NULL
``	NULL
and	NULL
may	NULL
therefore	NULL
exhibit	NULL
a	NULL
phenotype	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
our	NULL
VAD	NULL
mice	NULL
.	NULL

We	NULL
have	NULL
noted	NULL
that	NULL
optimal	NULL
resolution	NULL
of	NULL
the	NULL
GR-1'**	NULL
and	NULL
populations	NULL
appears	NULL
to	NULL
depend	NULL
on	NULL
the	NULL
fluorochrome	NULL
to	NULL
which	NULL
the	NULL
anti-GR-1	NULL
antibody	NULL
is	NULL
conjugated	NULL
;	NULL
FITC-conjugated	NULL
anti-GR-1	NULL
(	NULL
as	NULL
used	NULL
in	NULL
our	NULL
study	NULL
)	NULL
provided	NULL
the	NULL
best	NULL
resolution	NULL
,	NULL
while	NULL
other	NULL
conjugated	NULL
forms	NULL
of	NULL
this	NULL
antibody	NULL
appeared	NULL
to	NULL
give	NULL
more	NULL
compact	NULL
stainings	NULL
similar	NULL
to	NULL
those	NULL
shown	NULL
by	NULL
Kuwata	NULL
et	NULL
al	NULL
.	NULL
``	NULL

''	NULL
These	NULL
authors	NULL
also	NULL
found	NULL
less	NULL
apoptosis	NULL
within	NULL
the	NULL
granulocyte	NULL
population	NULL
of	NULL
their	NULL
VAD	NULL
mice	NULL
,	NULL
an	NULL
observation	NULL
that	NULL
they	NULL
used	NULL
to	NULL
explain	NULL
their	NULL
increase	NULL
in	NULL
granulocyte	NULL
numbers	NULL
.	NULL

Although	NULL
we	NULL
can	NULL
not	NULL
exclude	NULL
that	NULL
retinoids	NULL
directly	NULL
regulate	NULL
cell	NULL
survival	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
the	NULL
decrease	NULL
in	NULL
apoptosis	NULL
seen	NULL
by	NULL
Kuwata	NULL
and	NULL
colleagues	NULL
is	NULL
an	NULL
indirect	NULL
consequence	NULL
of	NULL
a	NULL
shift	NULL
toward	NULL
the	NULL
more	NULL
immature	NULL
stages	NULL
because	NULL
apoptosis	NULL
is	NULL
the	NULL
ultimate	NULL
endpoint	NULL
of	NULL
differentiation	NULL
.	NULL

The	NULL
finding	NULL
that	NULL
endogenous	NULL
unliganded	NULL
RARa	NULL
negatively	NULL
regulates	NULL
differentiation	NULL
is	NULL
consistent	NULL
with	NULL
results	NULL
from	NULL
previous	NULL
studies	NULL
showing	NULL
that	NULL
overexpression	NULL
of	NULL
WT	NULL
RARa	NULL
blocks	NULL
promyelocyte	NULL
differentiation	NULL
in	NULL
vitro	NULL
.	NULL

``	NULL
>	NULL
``	NULL
``	NULL
However	NULL
,	NULL
the	NULL
non-physiological	NULL
levels	NULL
of	NULL
receptor	NULL
expressed	NULL
in	NULL
these	NULL
systems	NULL
have	NULL
prevented	NULL
any	NULL
clear	NULL
conclusion	NULL
about	NULL
the	NULL
role	NULL
of	NULL
the	NULL
endogenous	NULL
molecule	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
these	NULL
latter	NULL
studies	NULL
often	NULL
claimed	NULL
that	NULL
the	NULL
overexpressed	NULL
receptors	NULL
functioned	NULL
in	NULL
a	NULL
dominant-negative	NULL
manner	NULL
by	NULL
titrating	NULL
out	NULL
retinoids	NULL
present	NULL
in	NULL
the	NULL
medium	NULL
,	NULL
thereby	NULL
countering	NULL
the	NULL
differentiating	NULL
role	NULL
of	NULL
these	NULL
compounds	NULL
.	NULL

Our	NULL
present	NULL
results	NULL
suggest	NULL
otherwise	NULL
;	NULL
the	NULL
differentiation	NULL
block	NULL
exerted	NULL
by	NULL
overexpressed	NULL
RARa	NULL
corresponds	NULL
to	NULL
an	NULL
amplification	NULL
of	NULL
an	NULL
intrinsic	NULL
inhibitory	NULL
activity	NULL
of	NULL
the	NULL
unliganded	NULL
receptor	NULL
.	NULL

It	NULL
is	NULL
important	NULL
to	NULL
stress	NULL
that	NULL
in	NULL
contrast	NULL
to	NULL
the	NULL
overexpression	NULL
studies	NULL
,	NULL
blocking	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
endogenous	NULL
receptor	NULL
in	NULL
vivo	NULL
or	NULL
in	NULL
vitro	NULL
(	NULL
with	NULL
VAD	NULL
or	NULL
BMS493	NULL
)	NULL
never	NULL
resulted	NULL
in	NULL
a	NULL
complete	NULL
arrest	NULL
in	NULL
differentiation	NULL
such	NULL
as	NULL
the	NULL
arrest	NULL
achieved	NULL
by	NULL
overexpressed	NULL
receptors	NULL
,	NULL
thereby	NULL
reflecting	NULL
the	NULL
possibility	NULL
that	NULL
RARa	NULL
is	NULL
expressed	NULL
in	NULL
limiting	NULL
amounts	NULL
.	NULL

Intriguingly	NULL
,	NULL
our	NULL
results	NULL
appear	NULL
to	NULL
contradict	NULL
those	NULL
of	NULL
Labrecque	NULL
et	NULL
al	NULL
,	NULL
'	NULL
``	NULL
who	NULL
reported	NULL
that	NULL
granulocytes	NULL
from	NULL
myeloid	NULL
BLOOD	NULL
,	NULL
1	NULL
MARCH	NULL
2001	NULL
«	NULL
VOLUME	NULL
97	NULL
,	NULL
NUMBER	NULL
5	NULL
colonies	NULL
derived	NULL
from	NULL
RARa1~-RARy~'~	NULL
neonatal	NULL
BM	NULL
cells	NULL
tend	NULL
to	NULL
be	NULL
more	NULL
immature	NULL
than	NULL
those	NULL
derived	NULL
from	NULL
WT	NULL
cells	NULL
(	NULL
RARa1	NULL
being	NULL
one	NULL
of	NULL
the	NULL
2	NULL
major	NULL
isoforms	NULL
produced	NULL
from	NULL
the	NULL
RARa	NULL
gene	NULL
)	NULL
.	NULL
``	NULL

As	NULL
we	NULL
never	NULL
observed	NULL
such	NULL
a	NULL
block	NULL
in	NULL
colonies	NULL
derived	NULL
from	NULL
RARa~-RARy~~-	NULL
FL	NULL
cells	NULL
,	NULL
the	NULL
apparent	NULL
difference	NULL
in	NULL
the	NULL
behavior	NULL
of	NULL
the	NULL
RARa1~-RARy~'~-	NULL
cells	NULL
might	NULL
be	NULL
due	NULL
to	NULL
the	NULL
persistent	NULL
expression	NULL
of	NULL
RARa2	NULL
,	NULL
an	NULL
isoform	NULL
not	NULL
present	NULL
in	NULL
our	NULL
double	NULL
mutants	NULL
.	NULL

It	NULL
should	NULL
be	NULL
noted	NULL
that	NULL
we	NULL
used	NULL
FL	NULL
cells	NULL
in	NULL
our	NULL
study	NULL
,	NULL
while	NULL
Labrecque	NULL
and	NULL
colleagues	NULL
'	NULL
``	NULL
used	NULL
BM	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
we	NULL
observed	NULL
a	NULL
similar	NULL
premature	NULL
differentiation	NULL
in	NULL
GM-CSF-dependent	NULL
colonies	NULL
derived	NULL
from	NULL
either	NULL
FL	NULL
or	NULL
adult	NULL
BM	NULL
RARa	NULL
«	NULL
~'~	NULL
cells	NULL
(	NULL
unpublished	NULL
observations	NULL
,	NULL
February	NULL
1998	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
appears	NULL
unlikely	NULL
that	NULL
RARs	NULL
control	NULL
granulopoiesis	NULL
differently	NULL
in	NULL
FL	NULL
and	NULL
BM	NULL
cells	NULL
.	NULL

With	NULL
respect	NULL
to	NULL
RARy	NULL
,	NULL
its	NULL
role	NULL
appears	NULL
to	NULL
be	NULL
minor	NULL
at	NULL
best	NULL
,	NULL
as	NULL
cells	NULL
lacking	NULL
only	NULL
RARa	NULL
are	NULL
already	NULL
resistant	NULL
to	NULL
the	NULL
effects	NULL
of	NULL
retinoids	NULL
.	NULL

The	NULL
present	NULL
results	NULL
demonstrate	NULL
that	NULL
granulocyte	NULL
differentiation	NULL
can	NULL
proceed	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
RARs	NULL
.	NULL

The	NULL
RA/RARa	NULL
pathway	NULL
is	NULL
therefore	NULL
not	NULL
an	NULL
obligatory	NULL
regulator	NULL
of	NULL
granulopoiesis	NULL
,	NULL
but	NULL
rather	NULL
a	NULL
modulator	NULL
of	NULL
this	NULL
differentiation	NULL
.	NULL

Both	NULL
retinoid	NULL
excess	NULL
and	NULL
deficiency	NULL
affect	NULL
granulopoiesis	NULL
,	NULL
suggesting	NULL
that	NULL
a	NULL
balance	NULL
between	NULL
liganded	NULL
and	NULL
unliganded	NULL
receptor	NULL
molecules	NULL
exists	NULL
in	NULL
vivo	NULL
under	NULL
normal	NULL
conditions	NULL
.	NULL

The	NULL
question	NULL
therefore	NULL
arises	NULL
as	NULL
to	NULL
which	NULL
physiological	NULL
or	NULL
pathological	NULL
conditions	NULL
modulate	NULL
retinoid	NULL
levels	NULL
.	NULL

Dietary	NULL
VAD	NULL
,	NULL
a	NULL
condition	NULL
that	NULL
is	NULL
associated	NULL
with	NULL
higher	NULL
susceptibility	NULL
to	NULL
bacterial	NULL
infections	NULL
,	NULL
is	NULL
an	NULL
obvious	NULL
candidate	NULL
.	NULL

The	NULL
negative	NULL
regulation	NULL
of	NULL
granulopoiesis	NULL
by	NULL
unliganded	NULL
RARa	NULL
«	NULL
(	NULL
which	NULL
ultimately	NULL
translates	NULL
into	NULL
an	NULL
elevated	NULL
granulocyte	NULL
pool	NULL
)	NULL
might	NULL
thus	NULL
represent	NULL
an	NULL
innate	NULL
response	NULL
used	NULL
to	NULL
off-set	NULL
VAD-associated	NULL
infections	NULL
.	NULL

In	NULL
this	NULL
view	NULL
,	NULL
an	NULL
important	NULL
role	NULL
of	NULL
RARa	NULL
«	NULL
during	NULL
granulopoiesis	NULL
could	NULL
paradoxically	NULL
be	NULL
to	NULL
mediate	NULL
the	NULL
effect	NULL
of	NULL
ligand	NULL
deficiency	NULL
.	NULL

Analysis	NULL
of	NULL
the	NULL
VAD	NULL
response	NULL
in	NULL
RARa~'-	NULL
mice	NULL
should	NULL
help	NULL
to	NULL
clarify	NULL
this	NULL
issue	NULL
.	NULL

At	NULL
the	NULL
molecular	NULL
level	NULL
,	NULL
several	NULL
downstream	NULL
candidates	NULL
might	NULL
mediate	NULL
the	NULL
actions	NULL
of	NULL
RARa	NULL
.	NULL

A	NULL
prime	NULL
candidate	NULL
is	NULL
C-EBPe	NULL
,	NULL
an	NULL
RA-target	NULL
gene	NULL
induced	NULL
by	NULL
RA	NULL
in	NULL
myeloid	NULL
cell	NULL
lines**	NULL
>	NULL
``	NULL
and	NULL
shown	NULL
to	NULL
be	NULL
essential	NULL
for	NULL
terminal	NULL
granulocyte	NULL
differentiation	NULL
.	NULL
``	NULL

However	NULL
,	NULL
because	NULL
granulocytes	NULL
can	NULL
fully	NULL
differentiate	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
RARs	NULL
or	NULL
during	NULL
retinoid	NULL
deficiency	NULL
,	NULL
it	NULL
is	NULL
unlikely	NULL
that	NULL
retinoids	NULL
are	NULL
the	NULL
only	NULL
regulators	NULL
of	NULL
C-EBPe	NULL
expression	NULL
in	NULL
vivo	NULL
.	NULL

In	NULL
this	NULL
respect	NULL
we	NULL
have	NULL
found	NULL
that	NULL
overall	NULL
,	NULL
C-EBPe	NULL
transcript	NULL
levels	NULL
were	NULL
not	NULL
altered	NULL
in	NULL
the	NULL
BM	NULL
of	NULL
RARa~~-	NULL
mice	NULL
(	NULL
unpublished	NULL
data	NULL
,	NULL
March	NULL
1998	NULL
)	NULL
.	NULL

Other	NULL
interesting	NULL
candidates	NULL
are	NULL
the	NULL
cdk	NULL
inhibitors	NULL
p21	NULL
and	NULL
p27	NULL
,	NULL
whose	NULL
increases	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
associated	NULL
with	NULL
the	NULL
transition	NULL
between	NULL
immature	NULL
,	NULL
proliferating	NULL
cells	NULL
and	NULL
post-mitotic	NULL
differentiated	NULL
cells	NULL
for	NULL
several	NULL
cell	NULL
types	NULL
including	NULL
myeloid	NULL
cells.44	NULL
>	NULL
Interestingly	NULL
,	NULL
p21	NULL
has	NULL
been	NULL
proposed	NULL
to	NULL
be	NULL
a	NULL
target	NULL
gene	NULL
for	NULL
nuclear	NULL
receptors	NULL
,	NULL
RARs	NULL
included.4	NULL
``	NULL
``	NULL
``	NULL
How	NULL
these	NULL
proteins	NULL
are	NULL
regulated	NULL
in	NULL
cells	NULL
lacking	NULL
RARa	NULL
thus	NULL
merits	NULL
further	NULL
investigation	NULL
.	NULL

Hox	NULL
genes	NULL
,	NULL
which	NULL
are	NULL
regulated	NULL
by	NULL
retinoic	NULL
acid	NULL
in	NULL
the	NULL
embryo	NULL
,	NULL
might	NULL
also	NULL
contribute	NULL
to	NULL
mediating	NULL
RAR	NULL
function	NULL
during	NULL
hematopoiesis	NULL
``	NULL
;	NULL
their	NULL
precise	NULL
role	NULL
during	NULL
granulopoiesis	NULL
,	NULL
however	NULL
,	NULL
and	NULL
their	NULL
possible	NULL
regulation	NULL
by	NULL
RARs	NULL
remain	NULL
unknown	NULL
.	NULL

Finally	NULL
,	NULL
Mad1	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
positively	NULL
regulate	NULL
cell	NULL
cycle	NULL
exit	NULL
during	NULL
granulopoiesis	NULL
,	NULL
possibly	NULL
by	NULL
antagonizing	NULL
the	NULL
effects	NULL
of	NULL
mye	NULL
proteins	NULL
.	NULL
``	NULL

''	NULL
Whether	NULL
the	NULL
Myc/Mad	NULL
and	NULL
the	NULL
RAR	NULL
pathways	NULL
are	NULL
parallel	NULL
or	NULL
convergent	NULL
modulators	NULL
of	NULL
granulopoiesis	NULL
remains	NULL
to	NULL
be	NULL
seen	NULL
.	NULL

The	NULL
role	NULL
of	NULL
retinoid	NULL
signaling	NULL
during	NULL
hematopoiesis	NULL
is	NULL
likely	NULL
to	NULL
extend	NULL
beyond	NULL
its	NULL
role	NULL
of	NULL
regulating	NULL
granulocyte	NULL
differentiation	NULL
described	NULL
here	NULL
.	NULL

RA	NULL
has	NULL
also	NULL
been	NULL
suggested	NULL
to	NULL
act	NULL
as	NULL
a	NULL
commitment	NULL
factor	NULL
for	NULL
the	NULL
granulocyte	NULL
lineage	NULL
,	NULL
as	NULL
exogenous	NULL
RA	NULL
is	NULL
able	NULL
to	NULL
From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

BLOOD	NULL
,	NULL
1	NULL
MARCH	NULL
2001	NULL
»	NULL
VOLUME	NULL
97	NULL
,	NULL
NUMBER	NULL
5	NULL
redirect	NULL
erythroid-	NULL
,	NULL
monocyte	NULL
,	NULL
or	NULL
eosinophil-committed	NULL
progenitors	NULL
toward	NULL
a	NULL
granulocyte	NULL
fate	NULL
.	NULL

``	NULL
*	NULL
``	NULL
``	NULL
Although	NULL
our	NULL
study	NULL
does	NULL
not	NULL
directly	NULL
address	NULL
this	NULL
issue	NULL
,	NULL
it	NULL
is	NULL
clear	NULL
that	NULL
other	NULL
factors	NULL
besides	NULL
RA	NULL
can	NULL
influence	NULL
granulocyte	NULL
lineage	NULL
commitment	NULL
,	NULL
as	NULL
commitment	NULL
was	NULL
not	NULL
impaired	NULL
in	NULL
RARa	NULL
«	NULL
~-RARy~'~-	NULL
double	NULL
mutants	NULL
or	NULL
upon	NULL
VAD	NULL
.	NULL

However	NULL
,	NULL
the	NULL
proportion	NULL
of	NULL
granulocytes	NULL
was	NULL
often	NULL
reduced	NULL
in	NULL
myeloid	NULL
colonies	NULL
derived	NULL
from	NULL
RARa	NULL
«	NULL
~~-	NULL
BM	NULL
cells	NULL
,	NULL
and	NULL
the	NULL
frequency	NULL
of	NULL
granulocyte-only	NULL
colonies	NULL
was	NULL
diminished	NULL
(	NULL
unpublished	NULL
data	NULL
,	NULL
October	NULL
1998	NULL
)	NULL
,	NULL
phenotypes	NULL
that	NULL
could	NULL
indicate	NULL
defective	NULL
granulocyte	NULL
commitment	NULL
in	NULL
the	NULL
mutants	NULL
.	NULL

The	NULL
present	NULL
effects	NULL
of	NULL
RAR	NULL
agonists	NULL
and	NULL
antagonists	NULL
during	NULL
terminal	NULL
granulocyte	NULL
differentiation	NULL
also	NULL
contrast	NULL
with	NULL
those	NULL
observed	NULL
when	NULL
similar	NULL
compounds	NULL
were	NULL
used	NULL
on	NULL
hematopoietic	NULL
stem	NULL
cells	NULL
,	NULL
where	NULL
RAR	NULL
agonists	NULL
and	NULL
antagonists	NULL
antagonized	NULL
and	NULL
promoted	NULL
their	NULL
differentiation	NULL
,	NULL
respec-tively	NULL
.	NULL
``	NULL

''	NULL
These	NULL
differences	NULL
suggest	NULL
a	NULL
complex	NULL
pattern	NULL
of	NULL
retinoid	NULL
receptor	NULL
function	NULL
during	NULL
hematopoiesis	NULL
.	NULL

Implications	NULL
for	NULL
APL	NULL
pathogenesis	NULL
RARa	NULL
chromosomal	NULL
rearrangements	NULL
represent	NULL
the	NULL
genetic	NULL
hallmark	NULL
of	NULL
APL	NULL
.	NULL

The	NULL
tight	NULL
association	NULL
between	NULL
RARa	NULL
alterations	NULL
and	NULL
APL	NULL
strongly	NULL
suggests	NULL
that	NULL
a	NULL
normal	NULL
RARa-dependent	NULL
function	NULL
must	NULL
be	NULL
altered	NULL
to	NULL
transform	NULL
promyelocytes	NULL
.	NULL

Generally	NULL
,	NULL
it	NULL
has	NULL
been	NULL
assumed	NULL
that	NULL
the	NULL
APL	NULL
RARa	NULL
fusion	NULL
proteins	NULL
act	NULL
as	NULL
dominant-negative	NULL
inhibitors	NULL
of	NULL
retinoid-dependent	NULL
differentiation	NULL
.	NULL
``	NULL

''	NULL
``	NULL
However	NULL
,	NULL
because	NULL
granulocyte	NULL
differentiation	NULL
is	NULL
only	NULL
partially	NULL
blocked	NULL
when	NULL
retinoid	NULL
signaling	NULL
through	NULL
RAR	NULL
is	NULL
prevented	NULL
,	NULL
dominant-negative	NULL
inhibition	NULL
of	NULL
retinoid-induced	NULL
differentiation	NULL
can	NULL
not	NULL
account	NULL
for	NULL
the	NULL
complete	NULL
differentiation	NULL
block	NULL
seen	NULL
in	NULL
APL	NULL
cells	NULL
.	NULL

Our	NULL
data	NULL
suggest	NULL
an	NULL
alternative	NULL
mechanism	NULL
of	NULL
action	NULL
for	NULL
the	NULL
RAR	NULL
fusion	NULL
proteins	NULL
:	NULL
enhancement	NULL
of	NULL
the	NULL
normal	NULL
inhibitory	NULL
function	NULL
of	NULL
unliganded	NULL
RARa	NULL
.	NULL

This	NULL
enhancement	NULL
may	NULL
be	NULL
due	NULL
to	NULL
an	NULL
overexpression	NULL
of	NULL
the	NULL
fusion	NULL
proteins	NULL
vis-a-vis	NULL
WT	NULL
RARa	NULL
,	NULL
as	NULL
is	NULL
often	NULL
observed	NULL
in	NULL
APL	NULL
cells	NULL
,	NULL
``	NULL
``	NULL
and/or	NULL
to	NULL
the	NULL
more	NULL
potent	NULL
repressive	NULL
properties	NULL
of	NULL
the	NULL
References	NULL
RARa	NULL
MODULATES	NULL
GRANULOPOIESIS	NULL
-	NULL
1319	NULL
fusion	NULL
proteins	NULL
themselves	NULL
.	NULL

In	NULL
this	NULL
respect	NULL
,	NULL
PML-RARa	NULL
and	NULL
PLZF-RARa	NULL
are	NULL
powerful	NULL
transcriptional	NULL
repressors	NULL
that	NULL
efficiently	NULL
recruit	NULL
histone	NULL
deacetylases	NULL
to	NULL
target	NULL
promoters	NULL
.	NULL
``	NULL

Interestingly	NULL
,	NULL
overexpression	NULL
of	NULL
thyroid	NULL
hormone	NULL
receptor	NULL
«	NULL
(	NULL
TRa	NULL
)	NULL
in	NULL
erythroid	NULL
precursors	NULL
blocks	NULL
their	NULL
differentiation	NULL
,	NULL
``	NULL
suggesting	NULL
that	NULL
the	NULL
differentiation	NULL
arrest	NULL
mediated	NULL
by	NULL
v-erbA	NULL
,	NULL
the	NULL
oncogenic	NULL
form	NULL
of	NULL
TRa	NULL
,	NULL
during	NULL
erythropoiesis	NULL
might	NULL
also	NULL
correspond	NULL
to	NULL
an	NULL
enhancement	NULL
of	NULL
a	NULL
normal	NULL
property	NULL
of	NULL
TRa	NULL
.	NULL

Different	NULL
nuclear	NULL
receptors	NULL
may	NULL
therefore	NULL
control	NULL
differentiation	NULL
and	NULL
leukemogenesis	NULL
in	NULL
distinct	NULL
hematopoietic	NULL
lineages	NULL
via	NULL
similar	NULL
mechanisms	NULL
.	NULL

If	NULL
interference	NULL
with	NULL
RARao-regulated	NULL
differentiation	NULL
appears	NULL
important	NULL
for	NULL
APL	NULL
pathogenesis	NULL
,	NULL
it	NULL
probably	NULL
represents	NULL
only	NULL
one	NULL
facet	NULL
of	NULL
the	NULL
action	NULL
of	NULL
RARa	NULL
fusion	NULL
proteins	NULL
in	NULL
APL	NULL
.	NULL

Fusion	NULL
of	NULL
RARa	NULL
with	NULL
PML	NULL
or	NULL
PLZF	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
required	NULL
to	NULL
provoke	NULL
APL	NULL
.	NULL

Dominant	NULL
interference	NULL
with	NULL
other	NULL
functions	NULL
,	NULL
such	NULL
as	NULL
those	NULL
of	NULL
PML	NULL
(	NULL
a	NULL
tumor	NULL
suppressor	NULL
gene	NULL
that	NULL
controls	NULL
apoptosis	NULL
and	NULL
p53	NULL
acetylation	NULL
)	NULL
,	NULL
is	NULL
likely	NULL
to	NULL
be	NULL
important	NULL
.	NULL
``	NULL

In	NULL
this	NULL
respect	NULL
the	NULL
coiled	NULL
coil	NULL
moiety	NULL
of	NULL
PML	NULL
appears	NULL
to	NULL
mediate	NULL
the	NULL
formation	NULL
of	NULL
high	NULL
molecular	NULL
weight	NULL
oligomeric	NULL
complexes	NULL
containing	NULL
both	NULL
PML-RARa	NULL
«	NULL
and	NULL
PML	NULL
,	NULL
complexes	NULL
which	NULL
could	NULL
disrupt	NULL
normal	NULL
PML	NULL
function	NULL
.	NULL
``	NULL

''	NULL
Simultaneous	NULL
targeting	NULL
of	NULL
several	NULL
cellular	NULL
functions	NULL
by	NULL
the	NULL
RARa	NULL
fusion	NULL
proteins	NULL
might	NULL
therefore	NULL
cooperate	NULL
to	NULL
transform	NULL
promyelocytes	NULL
.	NULL

Acknowledgments	NULL
We	NULL
thank	NULL
P.	NULL
Reczek	NULL
(	NULL
Bristol-Myers	NULL
Squibb	NULL
,	NULL
Princeton	NULL
,	NULL
NJ	NULL
)	NULL
for	NULL
providing	NULL
BMS493	NULL
and	NULL
M.	NULL
Sporn	NULL
for	NULL
C.	NULL
Bronn	NULL
,	NULL
B.	NULL
Bondeau	NULL
,	NULL
and	NULL
B.	NULL
Feret	NULL
for	NULL
excellent	NULL
technical	NULL
assistance	NULL
;	NULL
C.	NULL
Ebel	NULL
for	NULL
help	NULL
with	NULL
flow	NULL
cytometry	NULL
;	NULL
and	NULL
A.	NULL
Pailleux	NULL
,	NULL
F.	NULL
Fischer	NULL
,	NULL
and	NULL
P.	NULL
Michel	NULL
for	NULL
maintaining	NULL
the	NULL
mice	NULL
.	NULL

..	NULL
Melnick	NULL
A	NULL
,	NULL
Licht	NULL
JD	NULL
.	NULL

Deconstructing	NULL
a	NULL
disease	NULL
:	NULL
RARalpha	NULL
,	NULL
its	NULL
fusion	NULL
partners	NULL
,	NULL
and	NULL
their	NULL
roles	NULL
in	NULL
the	NULL
pathogenesis	NULL
of	NULL
acute	NULL
promyelocytic	NULL
leuke-	NULL
partner	NULL
of	NULL
retinoic	NULL
acid	NULL
receptor	NULL
alpha	NULL
in	NULL
acute	NULL
promyelocytic-like	NULL
leukaemia	NULL
.	NULL

Hum	NULL
Mol	NULL
Genet	NULL
.	NULL

1999	NULL
;	NULL
8:1741-1749.	NULL
.	NULL

He	NULL
LZ	NULL
,	NULL
Guidez	NULL
F	NULL
,	NULL
Tribioli	NULL
C	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Distinct	NULL
interac-	NULL
tions	NULL
of	NULL
PML-RARalpha	NULL
and	NULL
PLZF-RARalpha	NULL
with	NULL
co-repressors	NULL
determine	NULL
differential	NULL
re	NULL
S	NULL
,	NULL
Zelent	NULL
A	NULL
.	NULL

Reduced	NULL
retinoic	NULL
acid-sensitivities	NULL
of	NULL
nuclear	NULL
receptor	NULL
corepressor	NULL
binding	NULL
to	NULL
PML-	NULL
and	NULL
PLZF-RARalpha	NULL
underlie	NULL
molecular	NULL
pathogene-	NULL
sis	NULL
and	NULL
treatment	NULL
of	NULL
acute	NULL
promyelocytic	NULL
leukemia	NULL
.	NULL

Blood	NULL
.	NULL

1998	NULL
;	NULL
91:2634-2642.	NULL
h	NULL
``	NULL
16	NULL
.	NULL

ZelentA	NULL
,	NULL
Zhu	NULL
J	NULL
,	NULL
Lanotte	NULL
M	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Differential	NULL
ex-mia	NULL
.	NULL

Blood	NULL
.	NULL

1999	NULL
;	NULL
93:3167-3215.	NULL
sponses	NULL
to	NULL
RA	NULL
in	NULL
APL	NULL
.	NULL

Nat	NULL
Genet	NULL
.	NULL

1998	NULL
;	NULL
18:126-	NULL
pression	NULL
of	NULL
retinoid	NULL
receptors	NULL
during	NULL
multilineage	NULL
.	NULL

Lin	NULL
RJ	NULL
,	NULL
Egan	NULL
DA	NULL
,	NULL
Evans	NULL
RM	NULL
.	NULL

Molecular	NULL
genetics	NULL
135.	NULL
differentiation	NULL
of	NULL
haematopoietic	NULL
progenitor	NULL
cells	NULL
:	NULL
of	NULL
acute	NULL
promyelocytic	NULL
leukemia	NULL
.	NULL

Trends	NULL
Genet	NULL
.	NULL

10	NULL
.	NULL

Cheng	NULL
GX	NULL
,	NULL
Zhu	NULL
XH	NULL
,	NULL
Men	NULL
XQ	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Distinct	NULL
leu-	NULL
role	NULL
of	NULL
the	NULL
RARa2	NULL
isoform	NULL
in	NULL
normal	NULL
granulopoi-1999	NULL
;	NULL
15:179-184.	NULL
kemia	NULL
phenotypes	NULL
in	NULL
transgenic	NULL
mice	NULL
and	NULL
differ-	NULL
esis	NULL
and	NULL
leukemia	NULL
.	NULL

Blood	NULL
.	NULL

1997	NULL
;	NULL
90:44a	NULL
.	NULL

.	NULL

Kogan	NULL
SC	NULL
,	NULL
Bishop	NULL
JM	NULL
.	NULL

Acute	NULL
promyelocytic	NULL
leu-	NULL
ent	NULL
corepressor	NULL
interactions	NULL
generated	NULL
by	NULL
promy-	NULL
_	NULL
17	NULL
,	NULL
|	NULL
abrecque	NULL
J	NULL
,	NULL
Allan	NULL
D	NULL
,	NULL
Chambon	NULL
P	NULL
,	NULL
Iscove	NULL
NN	NULL
,	NULL
kemia	NULL
:	NULL
from	NULL
treatment	NULL
to	NULL
genetics	NULL
and	NULL
back	NULL
.	NULL

On-	NULL
elocytic	NULL
leukemia	NULL
variant	NULL
fusion	NULL
genes	NULL
PLZF-	NULL
Lohnes	NULL
D	NULL
,	NULL
Hoang	NULL
T.	NULL
Impaired	NULL
granulocytic	NULL
differ-cogene	NULL
.	NULL

1999	NULL
;	NULL
18:5261-5267	NULL
.	NULL

RABRalpha	NULL
and	NULL
NPM-RARalpha	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
entiation	NULL
in	NULL
vitro	NULL
in	NULL
hematopoietic	NULL
cells	NULL
lacking	NULL
.	NULL

Zhong	NULL
S	NULL
,	NULL
Salomoni	NULL
P	NULL
,	NULL
Pandolfi	NULL
PP	NULL
.	NULL

The	NULL
transcrip-	NULL
Sci	NULL
U	NULL
S	NULL
A	NULL
.	NULL

1999	NULL
;	NULL
96:6318-6323.	NULL
retinoic	NULL
acid	NULL
receptors	NULL
alpha1	NULL
and	NULL
gamma	NULL
.	NULL

Blood	NULL
.	NULL

tional	NULL
role	NULL
of	NULL
PML	NULL
and	NULL
the	NULL
nuclear	NULL
body	NULL
.	NULL

Nat	NULL
Cell	NULL
11	NULL
.	NULL

Kogan	NULL
SC	NULL
,	NULL
Hong	NULL
SH	NULL
,	NULL
Shultz	NULL
DB	NULL
,	NULL
Privalsky	NULL
ML	NULL
,	NULL
1998	NULL
;	NULL
92:607-615	NULL
.	NULL

Biol	NULL
.	NULL

2000	NULL
;	NULL
2	NULL
:	NULL
E85-E90	NULL
.	NULL

Bishop	NULL
JM	NULL
.	NULL

Leukemia	NULL
initiated	NULL
by	NULL
PMLRARalpha	NULL
:	NULL
__	NULL
18	NULL
.	NULL

Largman	NULL
C	NULL
,	NULL
Detmer	NULL
K	NULL
,	NULL
Corral	NULL
JC	NULL
,	NULL
Hack	NULL
FM	NULL
,	NULL
Law	NULL
.	NULL

Chen	NULL
2	NULL
,	NULL
Brand	NULL
NJ	NULL
,	NULL
Chon	NULL
A	NULL
otal	NULL
.	NULL

Fusionbameen	NULL
-	NULL
omen	NULL
--	NULL
rence	NULL
Expressionattaincie	NULL
teidrecoplor	NULL
a	NULL
novel	NULL
Kruppel-like	NULL
zinc	NULL
finger	NULL
gene	NULL
and	NULL
the	NULL
reti-	NULL
Blood	NULL
.	NULL

2000:95:1541-1550	NULL
ﬁes-7299	NULL
1'82	NULL
urman	NULL
'eukemia	NULL
ces	NULL
.	NULL

Blood	NULL
.	NULL

noic	NULL
acid	NULL
receptor-alpha	NULL
locus	NULL
due	NULL
to	NULL
a	NULL
variant	NULL
``	NULL
``	NULL
OC	NULL
``	NULL
P99	NULL
ONE	NULL
1	NULL
(	NULL
11	NULL
;	NULL
17	NULL
)	NULL
translocation	NULL
associated	NULL
with	NULL
acute	NULL
pro-	NULL
12	NULL
.	NULL

Hong	NULL
SH	NULL
,	NULL
David	NULL
G	NULL
,	NULL
Wong	NULL
CW	NULL
,	NULL
Dejean	NULL
A	NULL
,	NULL
Prival-	NULL
19	NULL
.	NULL

Breitman	NULL
TR	NULL
,	NULL
Selonick	NULL
SE	NULL
,	NULL
Collins	NULL
SJ	NULL
.	NULL

Induction	NULL
myelocytic	NULL
leukaemia	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

1993	NULL
;	NULL
12:1161-	NULL
sky	NULL
ML	NULL
.	NULL

SMART	NULL
corepressor	NULL
interacts	NULL
with	NULL
PLZF	NULL
of	NULL
differentiation	NULL
of	NULL
the	NULL
human	NULL
promyelocytic	NULL
leu-1167	NULL
.	NULL

and	NULL
with	NULL
the	NULL
PML-retinoic	NULL
acid	NULL
receptor	NULL
alpha	NULL
kemia	NULL
cell	NULL
line	NULL
(	NULL
HL-60	NULL
)	NULL
by	NULL
retinoic	NULL
acid	NULL
.	NULL

Proc	NULL
Nat	NULL
!	NULL

.	NULL

Wells	NULL
RA	NULL
,	NULL
Catzavelos	NULL
C	NULL
,	NULL
Kamel-Reid	NULL
S.	NULL
Fusion	NULL
of	NULL
(	NULL
RARglpha	NULL
)	NULL
a	NULL
.	NULL

“	NULL
PLZF-RARalpha	NULL
(	NULL
InncoproteIi	NULL
ns	NULL
Acad	NULL
Sci	NULL
U	NULL
S	NULL
A	NULL
.	NULL

1980	NULL
;	NULL
77:2936-2940.	NULL
retinoic	NULL
acid	NULL
receptor	NULL
alpha	NULL
to	NULL
NuMA	NULL
,	NULL
the	NULL
nuclear	NULL
associated	NULL
with	NULL
ac_ute	NULL
promyelctcytfc	NULL
leukemia	NULL
.	NULL

20	NULL
.	NULL

Gratas	NULL
C	NULL
,	NULL
Menot	NULL
ML	NULL
,	NULL
Dresch	NULL
C	NULL
,	NULL
Chomienne	NULL
C.	NULL
wou	NULL
.	NULL

.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
U	NULL
S	NULL
A	NULL
.	NULL

1997	NULL
;	NULL
94:9028-9033	NULL
.	NULL

200.	NULL
.	NULL

.	NULL

mitotic	NULL
apparatus	NULL
protein	NULL
,	NULL
by	NULL
a	NULL
variant	NULL
transloca-	NULL
Retinoid	NULL
acid	NULL
supports	NULL
granulocytic	NULL
but	NULL
not	NULL
ery-tion	NULL
in	NULL
acute	NULL
promyelocytic	NULL
leukaemia	NULL
.	NULL

Nat	NULL
Genet	NULL
.	NULL

__	NULL
13	NULL
.	NULL

Lin	NULL
RJ	NULL
,	NULL
Nagy	NULL
L	NULL
,	NULL
Inoue	NULL
S	NULL
,	NULL
Shao	NULL
W	NULL
,	NULL
Miller	NULL
WH	NULL
Jr	NULL
,	NULL
throid	NULL
differentiation	NULL
of	NULL
myeloid	NULL
progenitors	NULL
in	NULL
nor-1997	NULL
;	NULL
17:109-113	NULL
.	NULL

Evans	NULL
RM	NULL
.	NULL

Role	NULL
of	NULL
the	NULL
histone	NULL
deacetylase	NULL
com-	NULL
mal	NULL
bone	NULL
marrow	NULL
cells	NULL
.	NULL

Leukemia	NULL
.	NULL

1993	NULL
;	NULL
7:1156-	NULL
.	NULL

Redner	NULL
RL	NULL
,	NULL
Rush	NULL
EA	NULL
,	NULL
Faas	NULL
S	NULL
,	NULL
Rudert	NULL
WA	NULL
,	NULL
Corey	NULL
plex	NULL
in	NULL
acute	NULL
promyelocytic	NULL
leukaemia	NULL
.	NULL

Nature	NULL
.	NULL

1162	NULL
.	NULL

SJ	NULL
.	NULL

The	NULL
t	NULL
(	NULL
5	NULL
;	NULL
17	NULL
)	NULL
variant	NULL
of	NULL
acute	NULL
promyelocytic	NULL
leu-	NULL
1998	NULL
;	NULL
391:811-814	NULL
.	NULL

21	NULL
.	NULL

Tsai	NULL
S	NULL
,	NULL
Collins	NULL
SJ	NULL
.	NULL

A	NULL
dominant	NULL
negative	NULL
retinoic	NULL
kemia	NULL
expresses	NULL
a	NULL
nucleophosmin-retinoic	NULL
acid	NULL
14	NULL
.	NULL

Grignani	NULL
F	NULL
,	NULL
De	NULL
Matteis	NULL
S	NULL
,	NULL
Nervi	NULL
C	NULL
,	NULL
etal	NULL
.	NULL

Fusion	NULL
acid	NULL
receptor	NULL
blocks	NULL
neutrophil	NULL
differentiation	NULL
at	NULL
receptor	NULL
fusion	NULL
.	NULL

Blood	NULL
.	NULL

1996	NULL
;	NULL
87:882-886.	NULL
proteins	NULL
of	NULL
the	NULL
retinoic	NULL
acid	NULL
receptor-alpha	NULL
recruit	NULL
the	NULL
promyelocyte	NULL
stage	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
.	NULL

Amould	NULL
C	NULL
,	NULL
Philippe	NULL
C	NULL
,	NULL
Bourdon	NULL
V	NULL
,	NULL
Gregoire	NULL
MJ	NULL
,	NULL
histone	NULL
deacetylase	NULL
in	NULL
promyelocytic	NULL
leukaemia	NULL
.	NULL

U	NULL
S	NULL
A	NULL
.	NULL

1993	NULL
;	NULL
90:7153-7157	NULL
.	NULL

Berger	NULL
R	NULL
,	NULL
Jonveaux	NULL
P.	NULL
The	NULL
signal	NULL
transducer	NULL
and	NULL
Nature	NULL
.	NULL

1998	NULL
;	NULL
391:815-818	NULL
.	NULL

22	NULL
.	NULL

Onodera	NULL
M	NULL
,	NULL
Kunisada	NULL
T	NULL
,	NULL
Nishikawa	NULL
S	NULL
,	NULL
Sakiyama	NULL
activator	NULL
of	NULL
transcription	NULL
STATS5b	NULL
gene	NULL
is	NULL
a	NULL
new	NULL
15	NULL
.	NULL

Guidez	NULL
F	NULL
,	NULL
Ivins	NULL
S	NULL
,	NULL
Zhu	NULL
J	NULL
,	NULL
Soderstrom	NULL
M	NULL
,	NULL
Waxman	NULL
Y	NULL
,	NULL
Matsumoto	NULL
S.	NULL
Overexpression	NULL
of	NULL
retinoic	NULL
acid	NULL
receptor	NULL
alpha	NULL
suppresses	NULL
myeloid	NULL
cell	NULL
differentiation	NULL
at	NULL
the	NULL
promyelocyte	NULL
stage	NULL
.	NULL

Oncogene	NULL
.	NULL

1995	NULL
;	NULL
11:1291-1298	NULL
.	NULL

1320	NULL
23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

286	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

KASTNER	NULL
et	NULL
al	NULL
Du	NULL
C	NULL
,	NULL
Redner	NULL
RL	NULL
,	NULL
Cooke	NULL
MP	NULL
,	NULL
Lavau	NULL
C.	NULL
Overexpression	NULL
of	NULL
wild-type	NULL
retinoic	NULL
acid	NULL
receptor	NULL
alpha	NULL
(	NULL
RARalpha	NULL
)	NULL
recapitulates	NULL
retinoic	NULL
acid-sensitive	NULL
transformation	NULL
of	NULL
primary	NULL
myeloid	NULL
progenitors	NULL
by	NULL
acute	NULL
promyelocytic	NULL
leukemia	NULL
RARalpha-fusion	NULL
genes	NULL
.	NULL

Blood	NULL
.	NULL

1999	NULL
;	NULL
94:793-802	NULL
.	NULL

Tocci	NULL
A	NULL
,	NULL
Parolini	NULL
I	NULL
,	NULL
Gabbianelli	NULL
M	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Dual	NULL
action	NULL
of	NULL
retinoic	NULL
acid	NULL
on	NULL
human	NULL
embryonic/fetal	NULL
hematopoiesis	NULL
:	NULL
blockade	NULL
of	NULL
primitive	NULL
progenitor	NULL
proliferation	NULL
and	NULL
shift	NULL
from	NULL
multipotent/erythroid/	NULL
monocytic	NULL
to	NULL
granulocytic	NULL
differentiation	NULL
program	NULL
.	NULL

Blood	NULL
.	NULL

1996	NULL
;	NULL
88:2878-2888	NULL
.	NULL

Lufkin	NULL
T	NULL
,	NULL
Lohnes	NULL
D	NULL
,	NULL
Mark	NULL
M	NULL
,	NULL
et	NULL
al	NULL
.	NULL

High	NULL
postnatal	NULL
lethality	NULL
and	NULL
testis	NULL
degeneration	NULL
in	NULL
retinoic	NULL
acid	NULL
receptor	NULL
alpha	NULL
mutant	NULL
mice	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
U	NULL
S	NULL
A	NULL
.	NULL

1993	NULL
;	NULL
90:7225-7229	NULL
.	NULL

Lohnes	NULL
D	NULL
,	NULL
Kastner	NULL
P	NULL
,	NULL
Dierich	NULL
A	NULL
,	NULL
Mark	NULL
M	NULL
,	NULL
LeMeur	NULL
M	NULL
,	NULL
Chambon	NULL
P.	NULL
Function	NULL
of	NULL
retinoic	NULL
acid	NULL
receptor	NULL
gamma	NULL
in	NULL
the	NULL
mouse	NULL
.	NULL

Cell	NULL
.	NULL

1993	NULL
;	NULL
73:643-658	NULL
.	NULL

Ghyselinck	NULL
NB	NULL
,	NULL
Bavik	NULL
C	NULL
,	NULL
Sapin	NULL
V	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Cellular	NULL
retinol-binding	NULL
protein	NULL
|	NULL
is	NULL
essential	NULL
for	NULL
vitamin	NULL
A	NULL
homeostasis	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

1999	NULL
;	NULL
18:4903-4914	NULL
.	NULL

Lohnes	NULL
D	NULL
,	NULL
Mark	NULL
M	NULL
,	NULL
Mendelsohn	NULL
C	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Function	NULL
of	NULL
the	NULL
retinoic	NULL
acid	NULL
receptors	NULL
(	NULL
RARs	NULL
)	NULL
during	NULL
development	NULL
(	NULL
1	NULL
)	NULL
:	NULL
craniofacial	NULL
and	NULL
skeletal	NULL
abnormalities	NULL
in	NULL
RAR	NULL
double	NULL
mutants	NULL
.	NULL

Development	NULL
.	NULL

1994	NULL
;	NULL
120:2723-2748	NULL
.	NULL

Jacobsen	NULL
SE	NULL
,	NULL
Fahiman	NULL
C	NULL
,	NULL
Blomhoff	NULL
HK	NULL
,	NULL
Okken-haug	NULL
C	NULL
,	NULL
Rusten	NULL
LS	NULL
,	NULL
Smeland	NULL
EB	NULL
.	NULL

All-trans-	NULL
and	NULL
9-cis-retinoic	NULL
acid	NULL
:	NULL
potent	NULL
direct	NULL
inhibitors	NULL
of	NULL
primitive	NULL
murine	NULL
hematopoietic	NULL
progenitors	NULL
in	NULL
vitro	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
.	NULL

1994	NULL
;	NULL
179:1665-1670	NULL
.	NULL

Hestdal	NULL
K	NULL
,	NULL
Ruscetti	NULL
FW	NULL
,	NULL
Ihle	NULL
JN	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Characterization	NULL
and	NULL
regulation	NULL
of	NULL
RB6G-8C5	NULL
antigen	NULL
expression	NULL
on	NULL
murine	NULL
bone	NULL
marrow	NULL
cells	NULL
.	NULL

J	NULL
Immu-nol	NULL
.	NULL

1991	NULL
;	NULL
147:22-28	NULL
.	NULL

Nauss	NULL
KM	NULL
,	NULL
Mark	NULL
DA	NULL
,	NULL
Suskind	NULL
RM	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
vitamin	NULL
A	NULL
deficiency	NULL
on	NULL
the	NULL
in	NULL
vitro	NULL
cellular	NULL
immune	NULL
response	NULL
of	NULL
rats	NULL
.	NULL

J	NULL
Nutrit	NULL
.	NULL

1979	NULL
;	NULL
109:1815-1823	NULL
.	NULL

Nagy	NULL
L	NULL
,	NULL
Kao	NULL
HY	NULL
,	NULL
Chakravarti	NULL
D	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Nuclear	NULL
receptor	NULL
repression	NULL
mediated	NULL
by	NULL
a	NULL
complex	NULL
containing	NULL
SMART	NULL
,	NULL
mSin3A	NULL
,	NULL
and	NULL
histone	NULL
deacetylase	NULL
.	NULL

Cell	NULL
.	NULL

1997	NULL
;	NULL
89:373-380	NULL
.	NULL

Chen	NULL
JD	NULL
,	NULL
Evans	NULL
RM	NULL
.	NULL

A	NULL
transcriptional	NULL
co-repres-sor	NULL
that	NULL
interacts	NULL
with	NULL
nuclear	NULL
hormone	NULL
receptors	NULL
.	NULL

Nature	NULL
.	NULL

1995	NULL
;	NULL
377:454-457	NULL
.	NULL

Horlein	NULL
AJ	NULL
,	NULL
Naar	NULL
AM	NULL
,	NULL
Heinzel	NULL
T	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Ligand-in-dependent	NULL
repression	NULL
by	NULL
the	NULL
thyroid	NULL
hormone	NULL
receptor	NULL
mediated	NULL
by	NULL
a	NULL
nuclear	NULL
receptor	NULL
co-re-pressor	NULL
.	NULL

Nature	NULL
.	NULL

1995	NULL
;	NULL
377:397-404	NULL
.	NULL

Lawson	NULL
ND	NULL
,	NULL
Berliner	NULL
N.	NULL
Neutrophil	NULL
maturation	NULL
and	NULL
the	NULL
role	NULL
of	NULL
retinoic	NULL
acid	NULL
.	NULL

Exp	NULL
Hematol	NULL
.	NULL

1999	NULL
;	NULL
27:1355-1367	NULL
.	NULL

Kuwata	NULL
T	NULL
,	NULL
Wang	NULL
IM	NULL
,	NULL
Tamura	NULL
T	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Vitamin	NULL
A	NULL
37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48.	NULL
deficiency	NULL
in	NULL
mice	NULL
causes	NULL
a	NULL
systemic	NULL
expansion	NULL
of	NULL
myeloid	NULL
cells	NULL
.	NULL

Blood	NULL
.	NULL

2000	NULL
;	NULL
95:3349-3356	NULL
.	NULL

Leroy	NULL
P	NULL
,	NULL
Krust	NULL
A	NULL
,	NULL
Zelent	NULL
A	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Multiple	NULL
isoforms	NULL
of	NULL
the	NULL
mouse	NULL
retinoic	NULL
acid	NULL
receptor	NULL
alpha	NULL
are	NULL
generated	NULL
by	NULL
alternative	NULL
splicing	NULL
and	NULL
differential	NULL
in	NULL
duction	NULL
by	NULL
retinoic	NULL
acid	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

1991	NULL
;	NULL
10:59-69	NULL
.	NULL

Chih	NULL
DY	NULL
,	NULL
Chumakov	NULL
AM	NULL
,	NULL
Park	NULL
DJ	NULL
,	NULL
Silla	NULL
AG	NULL
,	NULL
Koet-fler	NULL
HP	NULL
.	NULL

Modulation	NULL
of	NULL
mRNA	NULL
expression	NULL
of	NULL
a	NULL
novel	NULL
human	NULL
myeloid-selective	NULL
CCAAT/enhancer	NULL
binding	NULL
protein	NULL
gene	NULL
(	NULL
C/EBP	NULL
epsilon	NULL
)	NULL
.	NULL

Blood	NULL
.	NULL

1997	NULL
;	NULL
90:2987-2994	NULL
.	NULL

Park	NULL
DJ	NULL
,	NULL
Chumakov	NULL
AM	NULL
,	NULL
Vuong	NULL
PT	NULL
,	NULL
et	NULL
al	NULL
.	NULL

CCAAT/	NULL
enhancer	NULL
binding	NULL
protein	NULL
epsilon	NULL
is	NULL
a	NULL
potential	NULL
retinoid	NULL
target	NULL
gene	NULL
in	NULL
acute	NULL
promyelocytic	NULL
leukemia	NULL
treatment	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
.	NULL

1999	NULL
;	NULL
103:1399-1408	NULL
.	NULL

Yamanaka	NULL
R	NULL
,	NULL
Barlow	NULL
C	NULL
,	NULL
Lekstrom-Himes	NULL
J	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Impaired	NULL
granulopoiesis	NULL
,	NULL
myelodysplasia	NULL
,	NULL
and	NULL
early	NULL
lethality	NULL
in	NULL
CCAAT/enhancer	NULL
binding	NULL
protein	NULL
epsilon-deficient	NULL
mice	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
U	NULL
S	NULL
A	NULL
.	NULL

1997	NULL
;	NULL
94:13187-13192	NULL
.	NULL

Liu	NULL
M	NULL
,	NULL
Lee	NULL
MH	NULL
,	NULL
Cohen	NULL
M	NULL
,	NULL
Bommakanti	NULL
M	NULL
,	NULL
Freedman	NULL
LP	NULL
.	NULL

Transcriptional	NULL
activation	NULL
of	NULL
the	NULL
Cdk	NULL
inhibitor	NULL
p21	NULL
by	NULL
vitamin	NULL
D3	NULL
leads	NULL
to	NULL
the	NULL
induced	NULL
differentiation	NULL
of	NULL
the	NULL
myelomonocytic	NULL
cell	NULL
line	NULL
U937	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

1996	NULL
;	NULL
10:142-153	NULL
.	NULL

Nakayama	NULL
K.	NULL
Cip/Kip	NULL
cyclin-dependent	NULL
kinase	NULL
inhibitors	NULL
:	NULL
brakes	NULL
of	NULL
the	NULL
cell	NULL
cycle	NULL
engine	NULL
during	NULL
development	NULL
.	NULL

Bioessays	NULL
.	NULL

1998	NULL
;	NULL
20:1020-1029	NULL
.	NULL

Taniguchi	NULL
T	NULL
,	NULL
Endo	NULL
H	NULL
,	NULL
Chikatsu	NULL
N	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Expression	NULL
of	NULL
p21	NULL
(	NULL
Cip1/Waf1/Sdi1	NULL
)	NULL
and	NULL
p27	NULL
(	NULL
Kip1	NULL
)	NULL
cyclin-dependent	NULL
kinase	NULL
inhibitors	NULL
during	NULL
human	NULL
hematopoiesis	NULL
.	NULL

Blood	NULL
.	NULL

1999	NULL
;	NULL
93:4167-4178	NULL
.	NULL

Muto	NULL
A	NULL
,	NULL
Kizaki	NULL
M	NULL
,	NULL
Yamato	NULL
K	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1,25-Dihy-droxyvitamin	NULL
D3	NULL
induces	NULL
differentiation	NULL
of	NULL
a	NULL
retinoic	NULL
acid-resistant	NULL
acute	NULL
promyelocytic	NULL
leukemia	NULL
cell	NULL
line	NULL
(	NULL
UF-1	NULL
)	NULL
associated	NULL
with	NULL
expression	NULL
of	NULL
p21	NULL
(	NULL
WAF1/CIP1	NULL
)	NULL
and	NULL
p27	NULL
(	NULL
KIP1	NULL
}	NULL
.	NULL

Blood	NULL
.	NULL

1999	NULL
;	NULL
93	NULL
:	NULL
2225-2233	NULL
.	NULL

Yaroslavskiy	NULL
B	NULL
,	NULL
Watkins	NULL
S	NULL
,	NULL
Donnenberg	NULL
AD	NULL
,	NULL
Patton	NULL
TJ	NULL
,	NULL
Steinman	NULL
RA	NULL
.	NULL

Subcellular	NULL
and	NULL
cell-cycle	NULL
expression	NULL
profiles	NULL
of	NULL
CDK-inhibitors	NULL
in	NULL
normal	NULL
differentiating	NULL
myeloid	NULL
cells	NULL
.	NULL

Blood	NULL
.	NULL

1999	NULL
;	NULL
93	NULL
:	NULL
2907-2917	NULL
.	NULL

Liu	NULL
M	NULL
,	NULL
Lavarone	NULL
A	NULL
,	NULL
Freedman	NULL
LP	NULL
.	NULL

Transcriptional	NULL
activation	NULL
of	NULL
the	NULL
human	NULL
p21	NULL
(	NULL
WAF1/CIP1	NULL
)	NULL
gene	NULL
by	NULL
retinoic	NULL
acid	NULL
receptor	NULL
:	NULL
correlation	NULL
with	NULL
retinoid	NULL
induction	NULL
of	NULL
U937	NULL
cell	NULL
differentiation	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
.	NULL

1996	NULL
;	NULL
271:31723-31728	NULL
.	NULL

Lawrence	NULL
HJ	NULL
,	NULL
Sauvageau	NULL
G	NULL
,	NULL
Humphries	NULL
RK	NULL
,	NULL
Largman	NULL
C.	NULL
The	NULL
role	NULL
of	NULL
HOX	NULL
homeobox	NULL
genes	NULL
in	NULL
normal	NULL
and	NULL
leukemic	NULL
hematopoiesis	NULL
.	NULL

Stem	NULL
Cells	NULL
.	NULL

1996	NULL
;	NULL
14:281-291	NULL
.	NULL

Foley	NULL
KP	NULL
,	NULL
McArthur	NULL
GA	NULL
,	NULL
Queva	NULL
C	NULL
,	NULL
Hurlin	NULL
PJ	NULL
,	NULL
Sori-ano	NULL
P	NULL
,	NULL
Eisenman	NULL
RN	NULL
.	NULL

Targeted	NULL
disruption	NULL
of	NULL
the	NULL
49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

BLOOD	NULL
,	NULL
1	NULL
MARCH	NULL
2001	NULL
«	NULL
VOLUME	NULL
97	NULL
,	NULL
NUMBER	NULL
5	NULL
MYC	NULL
antagonist	NULL
MAD1	NULL
inhibits	NULL
cell	NULL
cycle	NULL
exit	NULL
during	NULL
granulocyte	NULL
differentiation	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

1998	NULL
;	NULL
17	NULL
:	NULL
774-785	NULL
.	NULL

Paul	NULL
CC	NULL
,	NULL
Mahrer	NULL
S	NULL
,	NULL
Tolbert	NULL
M	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Changing	NULL
the	NULL
differentiation	NULL
program	NULL
of	NULL
hematopoietic	NULL
cells	NULL
:	NULL
retinoic	NULL
acid-induced	NULL
shift	NULL
of	NULL
eosinophil-committed	NULL
cells	NULL
to	NULL
neutrophils	NULL
.	NULL

Blood	NULL
.	NULL

1995	NULL
;	NULL
86:3737-3744	NULL
.	NULL

Purton	NULL
LE	NULL
,	NULL
Bernstein	NULL
ID	NULL
,	NULL
Collins	NULL
SJ	NULL
.	NULL

All-trans	NULL
retinoic	NULL
acid	NULL
enhances	NULL
the	NULL
long-term	NULL
repopulating	NULL
activity	NULL
of	NULL
cultured	NULL
hematopoietic	NULL
stem	NULL
cells	NULL
.	NULL

Blood	NULL
.	NULL

2000	NULL
;	NULL
95:470-477	NULL
.	NULL

Grignani	NULL
F	NULL
,	NULL
Ferrucci	NULL
PF	NULL
,	NULL
Testa	NULL
U	NULL
,	NULL
et	NULL
al	NULL
.	NULL

The	NULL
acute	NULL
promyelocytic	NULL
leukemia-specific	NULL
PML-RAR	NULL
alpha	NULL
fusion	NULL
protein	NULL
inhibits	NULL
differentiation	NULL
and	NULL
promotes	NULL
survival	NULL
of	NULL
myeloid	NULL
precursor	NULL
cells	NULL
.	NULL

Cell	NULL
.	NULL

1993	NULL
;	NULL
74:423-431	NULL
.	NULL

Rousselot	NULL
P	NULL
,	NULL
Hardas	NULL
B	NULL
,	NULL
Patel	NULL
A	NULL
,	NULL
et	NULL
al	NULL
.	NULL

The	NULL
PML-RAR	NULL
alpha	NULL
gene	NULL
product	NULL
of	NULL
the	NULL
t	NULL
(	NULL
15	NULL
;	NULL
17	NULL
)	NULL
translocation	NULL
inhibits	NULL
retinoic	NULL
acid-induced	NULL
granulocytic	NULL
differentiation	NULL
and	NULL
mediated	NULL
transactivation	NULL
in	NULL
human	NULL
myeloid	NULL
cells	NULL
.	NULL

Oncogene	NULL
.	NULL

1994	NULL
;	NULL
9:545-551	NULL
.	NULL

Kastner	NULL
P	NULL
,	NULL
Perez	NULL
A	NULL
,	NULL
Lutz	NULL
Y	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Structure	NULL
,	NULL
localization	NULL
and	NULL
transcriptional	NULL
properties	NULL
of	NULL
two	NULL
classes	NULL
of	NULL
retinoic	NULL
acid	NULL
receptor	NULL
alpha	NULL
fusion	NULL
proteins	NULL
in	NULL
acute	NULL
promyelocytic	NULL
leukemia	NULL
(	NULL
APL	NULL
)	NULL
:	NULL
structural	NULL
similarities	NULL
with	NULL
a	NULL
new	NULL
family	NULL
of	NULL
onco-proteins	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

1992	NULL
;	NULL
11:629-642	NULL
.	NULL

Pandolfi	NULL
PP	NULL
,	NULL
Alcalay	NULL
M	NULL
,	NULL
Fagioli	NULL
M	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Genomic	NULL
variability	NULL
and	NULL
alternative	NULL
splicing	NULL
generate	NULL
multiple	NULL
PML/RAR	NULL
alpha	NULL
transcripts	NULL
that	NULL
encode	NULL
aberrant	NULL
PML	NULL
proteins	NULL
and	NULL
PML/RAR	NULL
alpha	NULL
isoforms	NULL
in	NULL
acute	NULL
promyelocytic	NULL
leukaemia	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

1992	NULL
;	NULL
11:1397-1407	NULL
.	NULL

Bauer	NULL
A	NULL
,	NULL
Mikulits	NULL
W	NULL
,	NULL
Lagger	NULL
G	NULL
,	NULL
Steng	NULL
!	NULL

G	NULL
,	NULL
Brosch	NULL
G	NULL
,	NULL
Beug	NULL
H.	NULL
The	NULL
thyroid	NULL
hormone	NULL
receptor	NULL
functions	NULL
as	NULL
a	NULL
ligand-operated	NULL
developmental	NULL
switch	NULL
between	NULL
proliferation	NULL
and	NULL
differentiation	NULL
of	NULL
erythroid	NULL
progenitors	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

1998	NULL
;	NULL
17:4291-4303	NULL
.	NULL

Wang	NULL
ZG	NULL
,	NULL
Ruggero	NULL
D	NULL
,	NULL
Roncheitti	NULL
S	NULL
,	NULL
et	NULL
al	NULL
.	NULL

PML	NULL
is	NULL
essential	NULL
for	NULL
multiple	NULL
apoptotic	NULL
pathways	NULL
.	NULL

Nat	NULL
Genet	NULL
.	NULL

1998	NULL
;	NULL
20:266-272	NULL
.	NULL

Quignon	NULL
F	NULL
,	NULL
De	NULL
Bels	NULL
F	NULL
,	NULL
Koken	NULL
M	NULL
,	NULL
Feunteun	NULL
J	NULL
,	NULL
Ameisen	NULL
JC	NULL
,	NULL
de	NULL
The	NULL
H.	NULL
PML	NULL
induces	NULL
a	NULL
novel	NULL
caspase-independent	NULL
death	NULL
process	NULL
.	NULL

Nat	NULL
Genet	NULL
.	NULL

1998	NULL
;	NULL
20:259-265	NULL
.	NULL

Pearson	NULL
M	NULL
,	NULL
Carbone	NULL
R	NULL
,	NULL
Sebastiani	NULL
C	NULL
,	NULL
et	NULL
al	NULL
.	NULL

PML	NULL
regulates	NULL
p53	NULL
acetylation	NULL
and	NULL
premature	NULL
senes-cence	NULL
induced	NULL
by	NULL
oncogenic	NULL
Ras	NULL
.	NULL

Nature	NULL
.	NULL

2000	NULL
;	NULL
406:207-210	NULL
.	NULL

Minucci	NULL
S	NULL
,	NULL
Maccarana	NULL
M	NULL
,	NULL
Cioce	NULL
M	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Oli-gomerization	NULL
of	NULL
RAR	NULL
and	NULL
AML1	NULL
transcription	NULL
factors	NULL
as	NULL
a	NULL
novel	NULL
mechanism	NULL
of	NULL
oncogenic	NULL
activa-tion	NULL
.	NULL

Mol	NULL
Cell	NULL
.	NULL

2000	NULL
;	NULL
5:811-820	NULL
.	NULL

From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

®	NULL
2001	NULL
97	NULL
:	NULL
1314-1320	NULL
doi:10.1182/blood.V97.5.1314	NULL
Positive	NULL
and	NULL
negative	NULL
regulation	NULL
of	NULL
granulopoiesis	NULL
by	NULL
endogenous	NULL
RAR	NULL
C	NULL
4	NULL
_	NULL
5	NULL
,	NULL
'	NULL
_	NULL
>	NULL
,	NULL
#	NULL
04	NULL
;	NULL
@	NULL
``	NULL
20	NULL
Philippe	NULL
Kastner	NULL
,	NULL
H.	NULL
Jeffrey	NULL
Lawrence	NULL
,	NULL
Caroline	NULL
Waltzinger	NULL
,	NULL
Norbert	NULL
B.	NULL
Ghyselinck	NULL
,	NULL
Pierre	NULL
Chambon	NULL
and	NULL
Susan	NULL
Chan	NULL
Updated	NULL
information	NULL
and	NULL
services	NULL
can	NULL
be	NULL
found	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/content/97/5/1314.full.html	NULL
Articles	NULL
on	NULL
similar	NULL
topics	NULL
can	NULL
be	NULL
found	NULL
in	NULL
the	NULL
following	NULL
Blood	NULL
collections	NULL
Hematopoiesis	NULL
and	NULL
Stem	NULL
Cells	NULL
(	NULL
3573	NULL
articles	NULL
)	NULL
Information	NULL
about	NULL
reproducing	NULL
this	NULL
article	NULL
in	NULL
parts	NULL
or	NULL
in	NULL
its	NULL
entirety	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
requests	NULL
Information	NULL
about	NULL
ordering	NULL
reprints	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/misc/rights.xhtml	NULL
#	NULL
reprints	NULL
Information	NULL
about	NULL
subscriptions	NULL
and	NULL
ASH	NULL
membership	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/subscriptions/index.xhtml	NULL
Blood	NULL
(	NULL
print	NULL
ISSN	NULL
0006-4971	NULL
,	NULL
online	NULL
ISSN	NULL
1528-0020	NULL
)	NULL
,	NULL
is	NULL
published	NULL
weekly	NULL
by	NULL
the	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
,	NULL
2021	NULL
L	NULL
St	NULL
,	NULL
NW	NULL
,	NULL
Suite	NULL
900	NULL
,	NULL
Washington	NULL
DC	NULL
20036	NULL
.	NULL

Copyright	NULL
2011	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
;	NULL
all	NULL
rights	NULL
reserved	NULL
.	NULL

